<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Eur Respir J</span><span class="iso-abbrev" title="iso-abbrev">Eur. Respir. J</span><span class="publisher-id" title="publisher-id">ERJ</span><span class="hwp" title="hwp">erj</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">The European Respiratory Journal</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">0903-1936</span><span class="issn-epub" tagx="issn" title="issn-epub">1399-3003</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">European Respiratory Society</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7236830">7236830</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1183/13993003.00912-2020">10.1183/13993003.00912-2020</a></span><span class="publisher-id" title="publisher-id">ERJ-00912-2020</span><div class="unknown" title="article-version" tag="article-version">
Accepted Manuscript</div> <div class="article-categories" title="article-categories">
: <span class="subject" title="subject">State of the Art</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-0292-0594</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ingraham</span><span class="given-names" tagx="given-names" title="given-names">Nicholas E.</span></span><a href="#af1">1</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barakat</span><span class="given-names" tagx="given-names" title="given-names">Abdo G.</span></span><a href="#af2">2</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reilkoff</span><span class="given-names" tagx="given-names" title="given-names">Ronald</span></span><a href="#af1">1</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-2917-5237</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bezdicek</span><span class="given-names" tagx="given-names" title="given-names">Tamara</span></span><a href="#af3">3</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schacker</span><span class="given-names" tagx="given-names" title="given-names">Timothy</span></span><a href="#af4">4</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chipman</span><span class="given-names" tagx="given-names" title="given-names">Jeffrey G.</span></span><a href="#af5">5</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tignanelli</span><span class="given-names" tagx="given-names" title="given-names">Christopher J.</span></span><a href="#af5">5</a><a href="#af6">6</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Puskarich</span><span class="given-names" tagx="given-names" title="given-names">Michael A.</span></span><a href="#af7">7</a><a href="#af8">8</a></span></div><span class="citation_author_institution" id="af1">[1], </span><span class="citation_author_institution" id="af2">[2], </span><span class="citation_author_institution" id="af3">[3], </span><span class="citation_author_institution" id="af4">[4], </span><span class="citation_author_institution" id="af5">[5], </span><span class="citation_author_institution" id="af6">[6], </span><span class="citation_author_institution" id="af7">[7], </span><span class="citation_author_institution" id="af8">[8], </span><div class="author-notes" title="author-notes"> <div class="corresp" title="corresp">
Nicholas Ingraham, MMC 276, 420 Delaware St SE, Minneapolis, MN 55455. E-mail: <span class="email" tagx="email" title="email">ingra107@umn.edu</span></div> </div><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-4-4</span></span><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2020-4-4</span></span><span class="elocation-id" tagx="elocation-id" title="elocation-id">2000912</span><span class="history" title="history"><span class="received" title="received">received: 2020-3-30</span><span class="accepted" title="accepted">accepted: 2020-4-18</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"> <div tag="license_ref">
http://creativecommons.org/licenses/by-nc/4.0/</div><span class="license-p" title="license-p">This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="importance:" title="sec"> <div class="title" tagx="title" title="title">
Importance:</div> <p>Coronavirus Disease 19 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a global pandemic with significant morbidity and mortality since first appearing in Wuhan, China, in late 2019. As many countries are grappling with the onset of their epidemics, pharmacotherapeutics remain lacking. The window of opportunity to mitigate downstream morbidity and mortality is narrow but remains open. The renin-angiotensin-aldosterone system (RAAS) is crucial to the homeostasis of both the cardiovascular and respiratory systems. Importantly, SARS-CoV-2 utilises and interrupts this pathway directly, which could be described as the renin-angiotensin-aldosterone-SARS-CoV-2-axis (RAAS-SCoV-axis). There exists significant controversy and confusion surrounding how anti-hypertensive agents might function along this pathway. This review explores the current state of knowledge regarding the RAAS-SCoV-axis, informed by prior studies of SARS-CoV, how this relates to our currently evolving pandemic, and how these insights might guide our next steps in an evidence-based manner.</p> </div> <div class="observations:" title="sec"> <div class="title" tagx="title" title="title">
Observations:</div> <p>This review discusses the role of the RAAS-SCoV-axis in acute lung injury and the effects, risks, and benefits of pharmacologic modification of this axis. There may be an opportunity to leverage the different aspects of RAAS inhibitors to mitigate indirect viral-induced lung injury. Concerns have been raised that such modulation might exacerbate the disease. While relevant preclinical, experimental models to date favor a protective effect of RAAS-SCoV-axis inhibition on both lung injury and survival, clinical data related to the role of RAAS modulation in the setting of SARS-CoV-2 remains limited.</p> </div> <div class="conclusion:" title="sec"> <div class="title" tagx="title" title="title">
Conclusion:</div> <p>Proposed interventions for SARS-CoV-2 predominantly focus on viral microbiology and aim to inhibit viral cellular injury. While these therapies are promising, immediate use may not be feasible, and the time window of their efficacy remains a major unanswered question. An alternative approach is the modulation of the specific downstream pathophysiologic effects caused by virus that lead to morbidity and mortality. We propose a preponderance of evidence that supports clinical equipoise regarding the efficacy of RAAS-based interventions, and the imminent need for a multisite randomised controlled clinical trial to evaluate the inhibition of the RAAS-SCoV-axis on acute lung injury in COVID-19.</p> </div> </div> <div class="abstract" title="abstract"> <p>SARS-CoV-2â€™s interplay with the Renin-Angiotensin-Aldosterone-System likely accounts for much of its unique pathology. Appreciating the degree and mechanism of this interaction highlights potential therapeutic options, including blockade (ARBs).</p> </div> <div class="funding-group" title="funding-group"> <div class="funding" title="funding">
Funding</div> <div class="award-group" title="award-group"> <div class="funding-source" title="funding-source"> <div class="institution-wrap" title="institution-wrap"><span class="institution" title="institution">National Heart, Lung, and Blood Institute </span><span class="institution-id" title="institution-id">10.13039/100000050</span></div> </div><span class="award-id" tagx="award-id" title="award-id">T32HL07741</span></div> </div> </div> </div> <div class="body" title="body"> <div class="intro" title="intro"> <div class="title" tagx="title" title="title">
Introduction</div> <p>COVID-19, the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has left over 180 countries and territories grappling with a devastating pandemic. In December 2019, Wuhan, China, was identified as the epicenter of this outbreak. At the time of this submission, reported COVID-19 cases exceeded 700â€Š000, with more than 30â€Š000 deaths [<a href="#C1">1</a>â€"<a href="#C3">3</a>]. <i>(At time of article submission).</i> While early estimates vary and true values remain uncertain, mortality is estimated between 0.4 to 3.4% [<a href="#C4">4</a>, <a href="#C5">5</a>] with initial morbidity and mortality disproportionally affecting older patients [<a href="#C6">6</a>]. Infectivity (<i>R</i><sub>0</sub>) is estimated at 2.24 to 3.58 [<a href="#C4">4</a>, <a href="#C7">7</a>]. COVID-19-related hospitalisations are mostly due to the need for respiratory support and progressively higher levels of care, with respiratory failure being the underlying etiology of COVID-19-related deaths [<a href="#C8">8</a>, <a href="#C9">9</a>]. As many countries are struggling with the onset of their epidemics, pharmacotherapeutics remain lacking [<a href="#C10">10</a>, <a href="#C11">11</a>]. Learning from prior pandemics and related viruses can focus our efforts to control spread and treat those infected [<a href="#C12">12</a>].</p> <p>This novel coronavirus is closely related to the severe acute respiratory syndrome coronavirus (SARS-CoV), which caused an outbreak of disease (SARS) in 2003. Genetic studies found that SARS-CoV-2 shares almost 80% and 50% sequence identity with SARS-CoV and middle eastern respiratory virus coronavirus (MERS-CoV), respectively [<a href="#C13">13</a>]. The genetic variations between SARS-CoV and SARS-CoV-2 translate into differences in infectivity [<a href="#C14">14</a>] and immune response [<a href="#C15">15</a>]. Despite these differences, the shared genome translates into common clinical, microbiologic, and biochemical phenotypes. SARS-CoV-2 mimics SARS-CoV's mechanism of infection which utilises the angiotensin-converting enzyme 2 (ACE2), part of the renin-angiotensin-aldosterone system (RAAS). Following binding, ACE2 activity is downregulated through multiple mechanisms, preventing it from performing its usual function in states of health, further summarised below [<a href="#C13">13</a>, <a href="#C16">16</a>â€"<a href="#C18">18</a>]. The association between ACE2 and COVID-19 is rooted in two concepts: the mechanism of SARS-CoV-2 infection and the regulatory role of ACE2 during RAAS overactivation. Following the SARS outbreak, extensive research advanced our knowledge of highly morbid coronavirus infections [<a href="#C16">16</a>â€"<a href="#C25">25</a>]. The similar renin-angiotensin-aldosterone-SARS-CoV-2-axis (RAAS-SCoV-axis) interactions shared by the two coronaviruses provide an opportunity to further our understanding of this unique interplay in our pursuit of treatment options.</p> <p>Early attempts to develop safe and effective vaccines for SARS or MERS have been unsuccessful. It is hypothesised that current efforts will take time to develop, and may or may not be efficacious for this or future coronavirus pandemics [<a href="#C10">10</a>, <a href="#C26">26</a>â€"<a href="#C28">28</a>]. Many potential therapies have been proposed with a subset currently undergoing investigation [<a href="#C29">29</a>, <a href="#C30">30</a>]. Meanwhile, extensive efforts to date have been appropriately focused on screening, identification, and containment through the collaboration and coordination between global and local health and governmental agencies [<a href="#C31">31</a>]. Unfortunately, these public health efforts have had, at best, mixed success curbing the spread of the pandemic [<a href="#C32">32</a>]. Given the rapid spread of SARS-COV2 and the significant morbidity and mortality associated with infection, it behooves the medical community to evaluate and leverage novel treatments for efficacy, especially if they are already available and have an established safety profile.</p> <p>RAAS blockade has been proposed as a potential treatment for SARS-CoV-2 [<a href="#C33">33</a>â€"<a href="#C36">36</a>]. This hypothesis was initially published by Sun <i>et al.</i> [<a href="#C35">35</a>, <a href="#C37">37</a>] on February 4, 2020, and reinforced in a Drug Development Research publication on March 4, 2020 [<a href="#C33">33</a>]. Other reviews have voiced concern regarding the association between COVID-19 and cardiovascular disease [<a href="#C38">38</a>], going too far as to postulate that continued RAAS blockade may cause harm and recommend considering discontinuation [<a href="#C39">39</a>]. The previous argument is based on the observation that pharmacologic blockers of RAAS can upregulate ACE2 expression, which might increase viral entry into the cell [<a href="#C39">39</a>]. Evidence from human subjects to support such an assertation is scant, and as we will see in this review, preclinical and current observational Covid-19 evidence would support the contrary hypothesis â€" that discontinuation of RAAS blockade may prove harmful. These contrasting hypotheses underscore the dire need to evaluate potential mechanisms, if any, through which RAAS modulation would impact the pathophysiology of COVID-19 [<a href="#C35">35</a>, <a href="#C38">38</a>, <a href="#C40">40</a>]. In this review, we intend to compile the existing evidence in order to discuss how we might bridge knowledge gaps regarding the interplay between SARS-CoV-2, ACE2, and the RAAS.</p> </div> <div class="raasinstatesofhealth" title="sec"> <div class="title" tagx="title" title="title">
RAAS in states of health</div> <div class="overview" title="sec"> <div class="title" tagx="title" title="title">
Overview</div> <p>Renin, angiotensin, and aldosterone represent the core of a complex hormonal axis, referred to as RAAS, which contributes to blood pressure control, sodium reabsorption, inflammation, and fibrosis [<a href="#C41">41</a>]. RAAS imbalance or modification can cause or treat many diseases including heart failure, hypotension, diabetes, and atherosclerosis, respectively [<a href="#C42">42</a>]. This review focuses on several physiological and pathological effects of angiotensin II (Ang II) cell signaling (<a href="#F1">fig. 1</a>). </p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">FIGUREÂ 1</span></a></div>   <p>Renin-angiotensin system with COVID-19. ACEi angiotensin converting enzyme inhibitor, ACE1 angiotensin converting enzyme, ACE2 angiotensin converting enzyme 2, ARB angiotensin receptor blocker, AT<sub>1</sub>R type 1 angiotensin II receptor, AT<sub>2</sub>R type 2 angiotensin II receptor, rhACE2 recombinant human angiotensin converting enzyme 2.</p>   </div> </div> <div class="angiotensinii/at1receptorrelationship" title="sec"> <div class="title" tagx="title" title="title">
Angiotensin II/AT<sub>1</sub> receptor relationship</div> <p>Angiotensin II (Ang II), the primary physiological product of the RAAS system, is a potent vasoconstrictor. As illustrated in <a href="#F1">figure 1</a>, ACE catalyses the transformation of angiotensin I (Ang I) to Ang II. Ang II elicits its effects by activating two receptors: type 1 angiotensin II (AT<sub>1</sub>) receptor and type 2 angiotensin II (AT<sub>2</sub>) receptor [<a href="#C43">43</a>]. Ang II action through AT<sub>1</sub> receptor causes a cascade with resultant inflammation, vasoconstriction, and atherogenesis [<a href="#C44">44</a>]. These effects also promote insulin resistance and thrombosis [<a href="#C45">45</a>]. In contrast, AT<sub>2</sub> receptor stimulation causes vasodilation, decreased platelet aggregation, and the promotion of insulin action. However, the expression of AT<sub>2</sub> receptor is low in healthy adults [<a href="#C45">45</a>]. As such, Ang II's effects in adults are modulated and balanced indirectly by angiotensin II converting enzyme (ACE2), which converts Ang II into lung-protective Angiotensin-(1â€"7) (Ang- [1â€"7]), similar to effects seen from AT<sub>2</sub> receptor stimulation [<a href="#C41">41</a>, <a href="#C46">46</a>]. Conceptually grouping pathways into an Ang II/AT<sub>1</sub> receptor and its opposing pathway ACE2/Ang-(1â€"7) helps with understanding the countering forces and the sequelae when an imbalance occurs (<a href="#F1">fig. 1</a>).</p> <p>The consequences of excessive Ang II include pulmonary vasoconstriction, inflammatory, and cytokine-induced organ damage [<a href="#C47">47</a>] secondary to increased membrane permeability [<a href="#C48">48</a>], and increased epithelial cell apoptosis [<a href="#C49">49</a>]. The effects are predominantly mediated through the unopposed AT<sub>1</sub> receptor activation secondary to decreased ACE2 levels [<a href="#C50">50</a>]. Furthermore, the pro-inflammatory cascade [<a href="#C51">51</a>] and increased vascular permeability [<a href="#C48">48</a>] caused by over-activation of the AT<sub>1</sub> receptor in the lungs directly induce acute lung injury (ALI), acute respiratory distress syndrome (ARDS), and lead to death [<a href="#C10">10</a>, <a href="#C33">33</a>].</p> </div> <div class="angiotensin-convertingenzyme2" title="sec"> <div class="title" tagx="title" title="title">
Angiotensin-Converting enzyme 2</div> <p>ACE2 is expressed in many tissue types, including respiratory epithelial cells [<a href="#C52">52</a>]. ACE2 is predominantly expressed on the apical surface and converts Ang II into lung-protective Ang-(1â€"7) and Ang-(1â€"9) by catalysing a pathway that prevents unopposed AT<sub>1</sub> receptor activation. Therefore, ACE2 functions as a counterbalance to its structurally similar counterpart ACE [<a href="#C53">53</a>] through the conversion of Ang II into Ang-(1â€"7), which in contrast to ACE, promotes vasodilation, reduces proliferation, and prevents apoptosis [<a href="#C53">53</a>]. ACE2 levels are known to be low in healthy individuals [<a href="#C54">54</a>] and ACE2 levels decrease with age [<a href="#C55">55</a>]. Chronically elevated levels of ACE2 are an independent predictor of disease progression; but evidence suggests these changes are compensatory rather than causal [<a href="#C54">54</a>].</p> </div> <div class="aceisandarbs" title="sec"> <div class="title" tagx="title" title="title">
ACEis and ARBs</div> <p>Both angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) increase tissue and plasma levels of renin and Ang I.(50) ACEis inhibit Ang I to Ang II conversion, decreasing serum Ang II levels to baseline and have little to no affinity for ACE2 [<a href="#C56">56</a>]. At clinical doses, ACEis only partially affect this conversion because 40% of Ang II formation occurs outside the ACE pathway [<a href="#C57">57</a>]. ACE levels are in turn decreased through a negative feedback in states of high Ang II levels [<a href="#C58">58</a>]. Ang II levels increase in response to ARBs at all levels, except in the kidney. The consequence of this increase is a redirection of Ang II activity through the anti-inflammatory and vasodilatory ACE2 and AT<sub>2</sub> receptor pathways [<a href="#C56">56</a>]. As a result, ACE2, compared to ACE, regulates local levels of both Ang II and Ang-(1â€"7) to a greater degree [<a href="#C42">42</a>]. Tikellis <i>et al</i>. suggest that ARBs, therefore, have a higher potential to favorably rebalance the RAAS pathway compared to ACEi [<a href="#C42">42</a>]. Furthermore, the kallikrein-kinin system is regulated by ACE and ACE2. Increased activity of the kallikrein-kinin system occurs under proinflammatory conditions [<a href="#C59">59</a>], specifically bradykinin and des-Arg-BK<sup>9</sup>, which can lead to vascular leakage when unchecked by ACE and ACE2, respectively. This mechanism has been posited to be, at least in part, a cause of cough [<a href="#C60">60</a>] and pulmonary edema [<a href="#C61">61</a>], independent of proposed Ang II induced hydrostatic pressure. The dysregulated kallikrein-kinin system's role remains theoretical in COVID-19; however, if true, AT<sub>1</sub> receptor blockade may be favored (over ACE inhibition) in an attempt to preserve the regulatory mechanisms of this system [<a href="#C61">61</a>]. While there may still be a key role for ACE inhibition in the context of the current disease that we will elucidate in the following sections, these observations support our decision to narrow the focus of this review to the downstream RAAS modifiers, ARBs.</p> </div> </div> <div class="keypoints1" title="sec"> <div class="title" tagx="title" title="title">
Key Points 1</div> <ul> <li> <p>ACE2 levels are high in diseased states, likely secondary to an insufficient compensatory response to overactive RAAS activity</p> </li> <li> <p>In COVID-19, high rates of pulmonary edema and cough may be due, in part, to reduced breakdown of bradykinin from decreased ACE activity</p> </li> <li> <p>ARBs may provide crucial regulation to the overactive RAAS-SCoV-axis</p> </li> </ul> </div> <div class="raasincardiovasculardisease" title="sec"> <div class="title" tagx="title" title="title">
RAAS in cardiovascular disease</div> <p>Modulation of the RAAS axis is central to the management of cardiovascular disease [<a href="#C62">62</a>]. Cardiovascular disease, heart failure, atrial fibrillation, and kidney disease are associated with elevated levels of ACE2 [<a href="#C60">60</a>]. It is critical to discern if these elevations are a culprit or sequelae of disease in order to separate association from causation [<a href="#C63">63</a>]. More recent opinions suggest ACE2 represents as a biomarker, rather than a culprit, of cardiovascular disease [<a href="#C64">64</a>].</p> <p>Ramchand <i>et al</i>. demonstrated elevated ACE2 levels to be an independent risk factor of major adverse cardiac events in patients with known coronary artery disease, though this data, as noted by the authors, does not differentiate association <i>versus</i> causation [<a href="#C54">54</a>]. To begin to dissect this interplay, we turn to preclinical models, specifically ACE2 knockout mice that are characterised by severe cardiac defects. Critically, these defects are notably absent in double ACE and ACE2 knockout models which highlights the highly balanced interplay between ACE/Ang II/AT<sub>1</sub> and ACE2/Ang-(1â€"7) [<a href="#C53">53</a>, <a href="#C65">65</a>]. Similar protective effects to prevent cardiovascular events and strokes have been demonstrated in mouse models with overexpressed ACE2 [<a href="#C66">66</a>]. Rachmand <i>et al</i>. concluded that patients with elevated ACE2 might â€œreflect a persistent albeit insufficient counter-regulatory process to shift the balance away from the deleterious effects of sustained Ang II activation.â€� [<a href="#C54">54</a>] As such, ACE2 overexpression may be a <i>compensatory mechanism</i> to mitigate the effect of unopposed Ang II stimulation though increased degradation into protective Ang-(1â€"7) [<a href="#C67">67</a>].</p> <p>It is important to note that preclinical animal model treatment with losartan upregulates cardiac ACE2 mRNA expression and increases in ACE2 activity [<a href="#C68">68</a>, <a href="#C69">69</a>]. However, human studies found no significant difference in ACE2 plasma levels in patients treated with ACEi or ARBs have not confirmed such an effect, though local tissue ACE2 levels were not measured [<a href="#C54">54</a>]. Through anecdotal reports, COVID-19 may be associated with high rates of myocarditis and heart failure in the critically ill. While beyond the scope of this proposal, we will note that increased Ang II and decreased ACE2 are also associated with impaired cardiac contractility, which can be rescued with losartan [<a href="#C70">70</a>]. More observational data is needed to assess if other signs of RAAS overdrive (hypokalemia, hypertension) portend poor outcomes and may be associated with arrhythmias that have been noted in the diseases [<a href="#C71">71</a>]. Nevertheless, this could potentially underscore potential benefits of RAAS modulation that extend beyond the attenuation of lung injury.</p> </div> <div class="keypoints2" title="sec"> <div class="title" tagx="title" title="title">
Key Points 2</div> <ul> <li> <p>ACEis and ARBs interrupt maladaptive pathophysiologic responses to heightened activation of the RAAS.</p> </li> <li> <p>ARBs and ACEis mitigate the deleterious effects of unopposed AT1 receptor pathway activation, which in turn decreases inflammation, insulin resistance, and lung injury</p> </li> </ul> </div> <div class="raasinpulmonarydisease" title="sec"> <div class="title" tagx="title" title="title">
RAAS in pulmonary disease</div> <div class="chroniclungdisease" title="sec"> <div class="title" tagx="title" title="title">
Chronic lung disease</div> <p>In chronic obstructive lung disease (COPD), patients treated with ARBs (compared to those on ACEi) had less severe exacerbations, fewer exacerbations overall, lower mortality, lower mechanical ventilation requirements, and fewer hospitalisations [<a href="#C72">72</a>]. Moreover, veterans over 65 years old that were on ARBs before and during their hospitalisation for pneumonia had decreased mortality when compared to patients without such treatment [<a href="#C73">73</a>].</p> </div> <div class="acutelunginjury" title="sec"> <div class="title" tagx="title" title="title">
Acute lung injury</div> <p>Unopposed RAAS activation <i>via</i> the Ang II/AT<sub>1</sub> receptor causes inflammation [<a href="#C51">51</a>] increased vascular permeability [<a href="#C48">48</a>] and severe lung injury [<a href="#C10">10</a>, <a href="#C33">33</a>], while ARBs significantly attenuate these changes [<a href="#C48">48</a>â€"<a href="#C51">51</a>]. Importantly, the mere presence of high concentrations of Ang II can further regulate the expression of ACE2, leading to dysregulated Ang II/AT<sub>1</sub> receptor activity [<a href="#C74">74</a>]. In mice, losartan reduced mortality by blunting Ang II-associated increases in soluble epoxide hydrolase, a promoter of lung injury [<a href="#C75">75</a>]. Animal models of ventilator-associated lung injury have demonstrated benefit from losartan, mitigating Ang II activity and AT<sub>1</sub> receptor expression [<a href="#C76">76</a>â€"<a href="#C78">78</a>]. While most studies include pre-treated animal models, rescue models also demonstrate efficacy, with the restoration of ACE2 levels, blunting of PaO2 decline, and attenuation of lung injury [<a href="#C50">50</a>].</p> <p>In human patients, genetic cohort studies yield further insights into the relationship between RAAS and acute lung injury. Jerng <i>et al</i>. found that polymorphisms in the ACE gene are associated with outcomes in ARDS. These findings were corroborated by Adamzik <i>et al</i>., who identified patients with the ACE DD genotype (associated with increased ACE activity) to have the highest risk of ARDS-related death (HR 5.7) [<a href="#C79">79</a>]. Other human studies evaluating the association between RAAS-inhibition and ARDS remain observational. Kim <i>et al</i>. found ARDS patients that were taking ACEi or ARBs had better survival rates when compared to those without RAAS inhibition [<a href="#C80">80</a>]. A secondary analysis of a 2010 randomised control trial in patients with acute respiratory failure suggested that treatment with ACEi/ARB at discharge following an episode of acute respiratory failure was associated with a 44% reduction in 1-year mortality [<a href="#C81">81</a>]. More recently, Hsieh <i>et al</i>. observed lower adjusted odds of hospital mortality in patients with sepsis (with and without shock) who were on ARB or ACEi therapy [<a href="#C82">82</a>]. Mortenson <i>et al</i>. also found a 58% decrease in the odds of hospital mortality in patients taking ARBs before admission [<a href="#C83">83</a>]. Based on the above, there have been calls to further elucidate the potential benefits of ACEi and ARB in ARDS [<a href="#C84">84</a>]. However, randomised control trials around this topic were not identified in the peer-reviewed literature or clinicaltrials.gov at the time of this manuscript's preparation.</p> </div> <div class="pneumonia" title="sec"> <div class="title" tagx="title" title="title">
Pneumonia</div> <p>While influenza and other types of pneumonia may interact with the RAAS axis, both animal and human studies illustrate clear indirect effects on the RAAS in the setting of certain influenza strains in particular. Previous studies suggest Ang II levels predict mortality in undifferentiated patients with influenza [<a href="#C85">85</a>], and continuation of RAAS inhibitor therapy during admission is associated with decreased hospital mortality and odds of intubation in viral cases of pneumonia [<a href="#C86">86</a>]. RAAS may have implications for other viral pneumonias, as well, as Gu <i>et al</i>. found that children with respiratory syncytial virus tend to have higher Ang II levels compared to healthy children [<a href="#C87">87</a>]. Based on this observation, they demonstrated the benefit of recombinant ACE2 therapy on RSV infection in a preclinical mouse model.</p> <p>Critically, both H7N9 and H5N1 influenza have been shown to cause lung injury through ACE2 downregulation, upregulation of Ang II, and AT<sub>1</sub> receptor-induced lung injury [<a href="#C88">88</a>, <a href="#C89">89</a>]. Mouse models of H5N1 and H7N9 demonstrated decreased IL-6, lung edema, lung injury, and mortality if treated with losartan [<a href="#C89">89</a>, <a href="#C90">90</a>]. The mechanism by which losartan prevents lung injury may not reside solely within the RAAS pathway, however [<a href="#C51">51</a>]. Liu <i>et al</i>. suggest that losartan inhibits the activation of pulmonary dendritic cells [<a href="#C91">91</a>]. In a study of rats with <i>pseudomonas</i> pneumonia, AT<sub>1</sub> receptor blockers suppressed the activation of neutrophils through a mechanism that does not involve the AT<sub>1</sub> receptor down-regulation [<a href="#C51">51</a>, <a href="#C92">92</a>]. Such studies have raised concern that losartan treatment might decrease microbial clearance. In sharp contrast, study results actually demonstrate reduced viral loads [<a href="#C90">90</a>] and increased bacterial clearance [<a href="#C51">51</a>] in lung injury models treated with losartan. Given the complexity of these interactions, future investigations remain necessary to further elucidate these relationships.</p> </div> <div class="ace2bindingviralinfectionsars-cov" title="sec"> <div class="title" tagx="title" title="title">
ACE2 binding viral infection SARS-CoV</div> <p>In 2003, ACE2 was identified as the binding protein for SARS-CoV. In the years to follow, studies demonstrating the downstream consequences of downregulation of ACE2 with resultant increases in Ang II concentration illustrate the vicious cycle caused by the disruption of the RAAS, we refer to in this manuscript as RAAS-SARS-CoV-2 (RAAS-SCoV-axis) [<a href="#C18">18</a>]. Of relevance to the current pandemic, Wrapp <i>et al</i>. found SARS-CoV-2 to have a 10- to 20-fold higher affinity for ACE2 than SARS-CoV. The authors postulate this may cause increased infectivity, which may help explain the differences in the evolution of the two epidemics.</p> <p>Both SARS-coronaviruses contain four structural proteins, the nucleocapsid, membrane, envelope, and spike protein [<a href="#C93">93</a>]. The nucleocapsid, membrane, and envelope proteins have roles in viral replication, structural integrity, and host response among other mechanisms [<a href="#C93">93</a>]. The spike protein, known as the S-protein, is integral to attaching and infecting host cells [<a href="#C14">14</a>, <a href="#C93">93</a>]. Phan <i>et al</i>. identified specific deletions that increase the potential of the SARS-CoV-2 spike to evade immune responses over time. These changes have implications for both initial and subsequent infection severity, immunity, and the likelihood of developing an efficacious vaccine. More relevant to the current review, however, is the potential effect of such changes might have on the RAAS-SCoV-axis, which could serve to explain not only their predilection for causing respiratory failure but possibly other commonalities between these infections.</p> <p>SARS-CoV infection downregulates the surface expression of the binding protein, ACE2, a pivotal component for host cell entry [<a href="#C17">17</a>]. Notably, low ACE2 expression is associated with increased phenotype severity in <i>in-vitro</i> human airway epithelial cell studies [<a href="#C24">24</a>]. Imai <i>et al</i>. validated these findings in a whole animal model by demonstrating that loss of ACE2 in knockout (KO) mice leads to impairments in oxygenation, increased inflammation, and worsening of edema compared to WT mice after acid-induced lung injury [<a href="#C23">23</a>]. Pre-treatment with AT<sub>1</sub> receptor inhibitors before acid induced ARDS showed significantly lower lung injury, confirming the AT<sub>1</sub> receptor's role in the physiologic response [<a href="#C23">23</a>]. Subsequently and most critically, Kuba <i>et al</i>. demonstrated SARS-CoV spike protein augments Ang II increase and ACE2 downregulation, with resultant lung injury [<a href="#C17">17</a>]. In this model, losartan can attenuate the severity of acute lung injury due to SARS-CoV infection in both a pre-treatment model and a more clinically relevant post-infection (rescue) model [<a href="#C17">17</a>].</p> <p>Ensuing studies have confirmed and built upon these findings [<a href="#C19">19</a>]. AT<sub>1</sub> receptor blockade upregulates ACE2 through a negative feedback mechanism, and serve as a lung-protective mechanism through the increased conversion of Ang II to Ang-(1â€"7), effectively blunting pulmonary injury from the virus [<a href="#C50">50</a>]. These findings have led investigators to posit that the ACE2/Ang-(1â€"7) pathway may serve as a therapeutic target to combat the pathological effects of Ang II [<a href="#C74">74</a>]. To that end, there is already at least one trial of recombinant human ACE2 therapy for the treatment of COVID-19 that attempts to leverage this relationship and mitigate downstream lung injury [<a href="#C23">23</a>, <a href="#C35">35</a>].</p> <p>The mechanism by which SARS-CoV downregulates ACE2 may be relevant to the development of novel therapeutics, as well. Haga <i>et al</i>. demonstrated that SARS-CoV binding to ACE2 induces ACE2 shedding as a soluble form into the serum [<a href="#C20">20</a>], and further studies validated those findings [<a href="#C19">19</a>]. In addition, endocytosis of the ACE2 protein occurs after binding to SARS-CoV, further decreasing ACE2 activity [<a href="#C94">94</a>], with potential implications for Ang II/Ang1â€"7 balance described throughout this review. A final critical mechanism that cannot be overlooked includes the role of AT<sub>1</sub> receptor in the downregulation of ACE2. Desholtz <i>et al</i>. found that ACE2 downregulation induced persistent elevation of Ang II through local interaction with the AT<sub>1</sub> receptor, which triggers a vicious cycle where Ang II downregulates ACE2 leading to further increases in local tissue levels of Ang II [<a href="#C74">74</a>]. These mechanisms promote an unopposed Ang II/AT<sub>1</sub> receptor axis (<a href="#F1">fig. 1</a>).</p> <p>The ACE2-SARS/COVID-19 interplay has led to controversy with clinical implications. The finding that ACE2 KO mice are protected against SARS-CoV infection [<a href="#C17">17</a>] raises a concern that an upregulated ACE2 is harmful in the setting of SARS-CoV and COVID infections, as the virus cannot enter the cell. Conversely, ACE2 downregulation following infection is concerning considering the preclinical data summarised to this point, which instead suggests a putative causative mechanism of Ang II/Ang (1â€"7) in the evolution of SARS-CoV-2 associated acute lung injury. Even if abolishing ACE2 were feasible, Han <i>et al</i>. detected alternative receptors, DC/L-SIGN, which mediated SARS-CoV entry independently of ACE2 [<a href="#C21">21</a>].</p> </div> </div> <div class="keypoints3" title="sec"> <div class="title" tagx="title" title="title">
Key Points 3</div> <ul> <li> <p>SARS-CoV decreases surface expression of ACE2 during infection</p> </li> <li> <p>Decreased ACE2 activity leads to increased Ang II and further downregulation of ACE2 in a vicious cycle, driving acute lung injury.</p> </li> <li> <p>While the main point of entry involves ACE2, other receptors can independently mediate SARS-CoV infection</p> </li> </ul> </div> <div class="controversiesregardingthecausativeroleoface2incovid-19" title="sec"> <div class="title" tagx="title" title="title">
Controversies regarding the causative role of ACE2 in COVID-19</div> <p>Limited mechanistic investigations regarding COVID-19 currently exist [<a href="#C95">95</a>]. Early Chinese data illustrate a progressive increase in Ang-II levels among patients hospitalised in the setting of confirmed COVID-19 [<a href="#C96">96</a>], along with concomitant increasing levels of IL-6 levels, with the highest levels in non-survivors [<a href="#C97">97</a>]. Similarly, a 2014 analysis of H7N9 patients showed progressively increasing levels of Ang-II, up to 4â€…weeks following infection, a finding associated with a worse prognosis [<a href="#C89">89</a>]. In a recent COVID-19 patient study, quantified levels of Ang-II were positively correlated with viral titers and closely associated with PaO2/FiO2 measures, suggesting a relationship between infection, RAAS, and lung injury. Accordingly, the study investigators postulated that angiotensin receptor blockade might represent a promising therapeutic target [<a href="#C96">96</a>].</p> <p>As noted previously, ACE2 levels are known to be low in healthy individuals [<a href="#C54">54</a>], decrease with age, and are lower in men than in women [<a href="#C55">55</a>, <a href="#C98">98</a>]. Age is an independent risk factor for mortality in patients admitted with COVID-19 [<a href="#C97">97</a>]. The data also suggests a disproportionate rate of disease occurrence, severity, and worse outcomes in males compared to females during this pandemic [<a href="#C99">99</a>]. These associations might be interpreted to indicate that low ACE2 during times of health are appropriate, but the ability to regulate overactive RAAS or RAAS-SCoV-axis during illness is, at least in part, dependent on ACE2. For instance, one study identified a higher expression of the lung-protective AT<sub>2</sub> receptor among women, which could explain the disproportionately lower mortality in female COVID-19 subjects [<a href="#C100">100</a>]. Interestingly, ACE2 is located on the X-chromosome, which has been hypothesised to affect the ability of men to maintain adequate ACE2 production in situations of severe illness (<i>i.e.</i>, ARDS or COVID-19) [<a href="#C40">40</a>]</p> <p>Perhaps most importantly, the most common comorbidities of severely ill patients included hypertension, diabetes mellitus, and coronary heart diseases [<a href="#C9">9</a>]. These comorbidities are associated with either an overactivation of Ang II/AT<sub>1</sub> or a deficiency of ACE2 [<a href="#C42">42</a>, <a href="#C45">45</a>], and all have shown benefit from RAAS blockade in chronic conditions [<a href="#C101">101</a>], including an attenuation in AT<sub>1</sub> receptor expression with losartan [<a href="#C102">102</a>]. Furthermore, smoking tends to increase AT<sub>1</sub> receptor expression [<a href="#C102">102</a>] along with ACE2 expression in human and mouse epithelial cells [<a href="#C103">103</a>, <a href="#C104">104</a>]. RAAS activation in states of stress with high circulating Ang II levels may be particularly harmful for such patients, and could explain at least some of the observed clinical outcomes. Namely, data from China found the odds of disease progression in those with COVID-19 are 14 times higher in smokers [<a href="#C8">8</a>]. However, we acknowledge that misinterpreting association for causation can be dangerous and that the pathology underlying acute and chronic conditions may not be equivalent [<a href="#C105">105</a>]. Nevertheless, RAAS manipulation remains an attractive therapeutic target not to treat or prevent infection with COVID-19, but rather mitigate its downstream consequences.</p> <p>Side effects of RAAS manipulation are understandably a cause for concern, specifically hypotension and acute kidney injury in the setting of acute illness. The most severe risks of ARBs include teratogenicity in the setting of pregnancy, hypersensitivity including angioedema, symptomatic hypotension, worsening of renal function, and electrolyte abnormalities; however, the most common side effects of include fatigue, weakness, diarrhea, chest pain and anemia. Clinical trial and post-marketing surveillance data of losartan demonstrate an excellent safety profile. In over 4000 patients, there was a low incidence of adverse events (2.1%) comparable to placebo (3.7%) [<a href="#C106">106</a>]. The effects more common in losartan than placebo were clinically minor, including dizziness (3% <i>versus</i> 2%), upper respiratory infection (8% <i>versus</i> 7%), nasal congestion (2% <i>versus</i> 1%) and back pain (2% <i>versus</i> 1%). While losartan has the potential to cause symptomatic hypotension, four studies have identified losartan has a negligible effect on resting blood pressure and heart rate in healthy volunteers [<a href="#C107">107</a>â€"<a href="#C110">110</a>]. These reassuring data cannot be extrapolated to COVID-19 patients; however, when assessing the risk/benefit balance for RAAS modulation, the baseline risk appears low in the healthy population whereas repurposing of other medications may not have the same favorable profile. There are also concerns that the upregulation of ACE2 by ARBs could accelerate SARS-CoV-2 entry in host cells. Such concerns become more relevant when one considers the observation that patients with hypertension tend to have worse outcomes, and many patients with hypertension are on agents that might upregulate ACE2 expression. Consequently, some clinicians have argued for discontinuing ACEi and ARBs and switching their patients to different anti-hypertensive classes. However, to our knowledge, there is no data to suggest such a change is beneficial, nor are there well controlled, risk adjusted analyses demonstrating that these medications are harmful.</p> <p>On the contrary, data summarised in this review actually suggests that discontinuation of ACEi or ARBs could pose a serious risk of harm through the propagation of excessive Ang II mediated acute lung injury and downregulation of protective ACE2. To this point, in a recent preprint, Liu <i>et al.</i> retrospectively studied 511 COVID-19 patients (age &amp;gt;65â€…years old) with hypertension. Patients were categorised based on home anti-hypertensive regimen. Patients on ARBs had significantly decreased odds of developing severe COVID-19 disease on univariate analysis (OR 0.34, p=0.025) and multivariable analysis (OR 0.25, p=0.046), while none of the other medications demonstrated improved outcomes. Two subsequent retrospective studies have demonstrated a protective effect of RAS blockade, including significant reductions in viral load [<a href="#C111">111</a>, <a href="#C112">112</a>]. Finally, in addition to the inhibitory effects on AT1R, a pre-print publication from Iran [<a href="#C113">113</a>] identified losartan as a potential candidate treatment based on molecular docking and dynamic simulation. In addition to the effects on angiotensin homeostasis, therefore, losartan may directly inhibit the viral macrodomain and cell cycle [<a href="#C113">113</a>]. Even prior to these observational data, based on pre-clinical evidence and non-COVID-19 studies, the International Society of Hypertension, the European Society of Cardiology, and other international committees have strongly recommended that physicians and patients continue treatment with their usual anti-hypertensive therapy as there is no clinical or scientific evidence to suggest that treatment with ACEi or ARBs should be discontinued in the setting of the SARS-CoV-2 pandemic at the current time [<a href="#C114">114</a>â€"<a href="#C116">116</a>].</p> </div> <div class="conclusion" title="sec"> <div class="title" tagx="title" title="title">
Conclusion</div> <p>Current clinical evidence is insufficient to recommend treating with or withholding RAAS blockade during this pandemic. Despite elevated ACE2 levels being found in chronic disease states, the upregulation of ACE2 seems more likely an adaptive response rather than a culprit [<a href="#C67">67</a>]. Significant preclinical data and retrospective human data suggest RAAS inhibition decreases lung injury and improves survival, while simultaneously decreasing viral load in animal models with viral infections that utilise the ACE2 receptor. Human clinical data regarding the effects of RAAS inhibitors on outcomes remain modest and an area of active investigation. While the association between hypertension and poor outcomes might be mediated through ACE2 upregulation and increasing viral susceptibility, these differential outcomes are at least as likely to be a result of dysregulated Ang II-mediated lung injury. We believe this represents a state of clinical equipoise and hypothesise that RAAS inhibition may improve outcomes in patients infected with COVID-19. Furthermore, the wide spectrum of severity during the pandemic highlights the heterogeneity in the patients with COVID-19. As different phenotypes emerge, certain subgroups (<i>i.e.</i> those with overactive RAAS) may differ in their response to therapy. Time will also need to be considered. RAAS modulation may have significantly different effects early in the disease process compared to later given the complexity of the RAAS-SCoV-axis. This underscores the exigency for high-quality evidence to investigate any significant association between RAAS modulation and pulmonary pathophysiology, with a focus on ACE2-mediated viral infections, particularly, SARS-CoV-2.</p> <p>TABLEÂ 1 Summary (in text).</p> <p>TABLEÂ 2 Summary (in text)</p> <p>TABLEÂ 3 Summary (in text)</p> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgments</div> <p>We gratefully acknowledge the editorial assistance of Michael Lotti, Senior Editor of the University of Minnesota's Institute for Engineering in Medicine.</p> </div> <div class="fn-group" title="fn-group"> <div class="fn-type-other" title="other"> <p>Reprints will not be available from the authors. All authors significantly contributed to developing, writing, and revising this manuscript.</p> </div> <div class="fn-type-financial-disclosure" title="financial-disclosure"> <p>Funder: National Heart, Lung, and Blood Institute; DOI: http://dx.doi.org/10.13039/100000050; Grant: T32HL07741.</p> </div> <div class="fn-type-COI-statement" title="COI-statement"> <p>Conflict of interest: Dr. Ingraham has nothing to disclose.</p> </div> <div class="fn-type-COI-statement" title="COI-statement"> <p>Conflict of interest: Dr. Barakat has nothing to disclose.</p> </div> <div class="fn-type-COI-statement" title="COI-statement"> <p>Conflict of interest: Dr. Reilkoff has nothing to disclose.</p> </div> <div class="fn-type-COI-statement" title="COI-statement"> <p>Conflict of interest: Dr. Bezdicek has nothing to disclose.</p> </div> <div class="fn-type-COI-statement" title="COI-statement"> <p>Conflict of interest: Dr. Schacker has nothing to disclose.</p> </div> <div class="fn-type-COI-statement" title="COI-statement"> <p>Conflict of interest: Dr. Chipman has nothing to disclose.</p> </div> <div class="fn-type-COI-statement" title="COI-statement"> <p>Conflict of interest: Dr. Tignanelli has nothing to disclose.</p> </div> <div class="fn-type-COI-statement" title="COI-statement"> <p>Conflict of interest: Dr. Puskarich has nothing to disclose.</p> </div> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="C1" /><span class="label" tagx="label" title="label">1</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gardner</span><span class="given-names" tagx="given-names" title="given-names">L</span></span></span><span class="mixed-article-title" title="mixed-article-title">An interactive web-based dashboard to track COVID-19 in real time</span>. <span class="source" tagx="source" title="source">Lancet Infect Dis</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C2" /><span class="label" tagx="label" title="label">2</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="comment">Coronavirus COVID-19 (2019-nCoV)</span><a href="www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6">www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6</a>.</span></li> <li tag="ref"><a name="C3" /><span class="label" tagx="label" title="label">3</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="comment">Novel Coronavirus (2019-nCoV) situation reports</span><a href="www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports">www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</a>.</span></li> <li tag="ref"><a name="C4" /><span class="label" tagx="label" title="label">4</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures</span>. <span class="source" tagx="source" title="source">J Med Virol</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C5" /><span class="label" tagx="label" title="label">5</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rajgor</span><span class="given-names" tagx="given-names" title="given-names">DD</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">MH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Archuleta</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">The many estimates of the COVID-19 case fatality rate</span>. <span class="source" tagx="source" title="source">Lancet Infect Dis</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C6" /><span class="label" tagx="label" title="label">6</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="collab'">collab: World Health O</span></span><span class="comment">Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C7" /><span class="label" tagx="label" title="label">7</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ran</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak</span>. <span class="source" tagx="source" title="source">Int J Infect Dis</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">92</span>: <span class="fpage" tagx="fpage" title="fpage">214</span>â€"<span class="lpage" tagx="lpage" title="lpage">217</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ijid.2020.01.050">10.1016/j.ijid.2020.01.050</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32007643">32007643</a></span></span></li> <li tag="ref"><a name="C8" /><span class="label" tagx="label" title="label">8</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tao</span><span class="given-names" tagx="given-names" title="given-names">ZW</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lei</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease</span>. <span class="source" tagx="source" title="source">Chin Med J (Engl)</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C9" /><span class="label" tagx="label" title="label">9</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guan</span><span class="given-names" tagx="given-names" title="given-names">WJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ni</span><span class="given-names" tagx="given-names" title="given-names">ZY</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical Characteristics of Coronavirus Disease 2019 in China</span>. <span class="source" tagx="source" title="source">N Engl J Med</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C10" /><span class="label" tagx="label" title="label">10</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Penninger</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target</span>. <span class="source" tagx="source" title="source">Intensive Care Med</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">46</span>: <span class="fpage" tagx="fpage" title="fpage">586</span>â€"<span class="lpage" tagx="lpage" title="lpage">590</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1007/s00134-020-05985-9">10.1007/s00134-020-05985-9</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32125455">32125455</a></span></span></li> <li tag="ref"><a name="C11" /><span class="label" tagx="label" title="label">11</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ingraham</span><span class="given-names" tagx="given-names" title="given-names">NE</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tignanelli</span><span class="given-names" tagx="given-names" title="given-names">CJ</span></span></span><span class="mixed-article-title" title="mixed-article-title">Fact Versus Science Fiction</span>. <span class="source" tagx="source" title="source">Crit Care Explor</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">2</span>: <span class="fpage" tagx="fpage" title="fpage">e0108</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1097/CCE.0000000000000108">10.1097/CCE.0000000000000108</a></span></span></li> <li tag="ref"><a name="C12" /><span class="label" tagx="label" title="label">12</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kuba</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Imai</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rao</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Lessons from SARS: control of acute lung failure by the SARS receptor ACE2</span>. <span class="source" tagx="source" title="source">J Mol Med</span><span class="year" tagx="year" title="year">2006</span>; <span class="volume" tagx="volume" title="volume">84</span>: <span class="fpage" tagx="fpage" title="fpage">814</span>â€"<span class="lpage" tagx="lpage" title="lpage">820</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1007/s00109-006-0094-9">10.1007/s00109-006-0094-9</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16988814">16988814</a></span></span></li> <li tag="ref"><a name="C13" /><span class="label" tagx="label" title="label">13</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">XL</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">XG</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">A pneumonia outbreak associated with a new coronavirus of probable bat origin</span>. <span class="source" tagx="source" title="source">Nature</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">579</span>: <span class="fpage" tagx="fpage" title="fpage">270</span>â€"<span class="lpage" tagx="lpage" title="lpage">273</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/s41586-020-2012-7">10.1038/s41586-020-2012-7</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32015507">32015507</a></span></span></li> <li tag="ref"><a name="C14" /><span class="label" tagx="label" title="label">14</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wrapp</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Corbett</span><span class="given-names" tagx="given-names" title="given-names">KS</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</span>. <span class="source" tagx="source" title="source">Science</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">367</span>: <span class="fpage" tagx="fpage" title="fpage">1260</span>â€"<span class="lpage" tagx="lpage" title="lpage">1263</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1126/science.abb2507">10.1126/science.abb2507</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32075877">32075877</a></span></span></li> <li tag="ref"><a name="C15" /><span class="label" tagx="label" title="label">15</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Phan</span><span class="given-names" tagx="given-names" title="given-names">T</span></span></span><span class="mixed-article-title" title="mixed-article-title">Genetic diversity and evolution of SARS-CoV-2</span>. <span class="source" tagx="source" title="source">Infect Genet Evol</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">81</span>: <span class="fpage" tagx="fpage" title="fpage">104260</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.meegid.2020.104260">10.1016/j.meegid.2020.104260</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32092483">32092483</a></span></span></li> <li tag="ref"><a name="C16" /><span class="label" tagx="label" title="label">16</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dijkman</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jebbink</span><span class="given-names" tagx="given-names" title="given-names">MF</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Deijs</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63</span>. <span class="source" tagx="source" title="source">J Gen Virol</span><span class="year" tagx="year" title="year">2012</span>; <span class="volume" tagx="volume" title="volume">93</span>: <span class="issue" tagx="issue" title="issue">Pt 9</span>, <span class="fpage" tagx="fpage" title="fpage">1924</span>â€"<span class="lpage" tagx="lpage" title="lpage">1929</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1099/vir.0.043919-0">10.1099/vir.0.043919-0</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22718567">22718567</a></span></span></li> <li tag="ref"><a name="C17" /><span class="label" tagx="label" title="label">17</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kuba</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Imai</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rao</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury</span>. <span class="source" tagx="source" title="source">Nat Med</span><span class="year" tagx="year" title="year">2005</span>; <span class="volume" tagx="volume" title="volume">11</span>: <span class="fpage" tagx="fpage" title="fpage">875</span>â€"<span class="lpage" tagx="lpage" title="lpage">879</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/nm1267">10.1038/nm1267</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16007097">16007097</a></span></span></li> <li tag="ref"><a name="C18" /><span class="label" tagx="label" title="label">18</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moore</span><span class="given-names" tagx="given-names" title="given-names">MJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vasilieva</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus</span>. <span class="source" tagx="source" title="source">Nature</span><span class="year" tagx="year" title="year">2003</span>; <span class="volume" tagx="volume" title="volume">426</span>: <span class="fpage" tagx="fpage" title="fpage">450</span>â€"<span class="lpage" tagx="lpage" title="lpage">454</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/nature02145">10.1038/nature02145</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14647384">14647384</a></span></span></li> <li tag="ref"><a name="C19" /><span class="label" tagx="label" title="label">19</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Glowacka</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bertram</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Herzog</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63</span>. <span class="source" tagx="source" title="source">J Virol</span><span class="year" tagx="year" title="year">2010</span>; <span class="volume" tagx="volume" title="volume">84</span>: <span class="fpage" tagx="fpage" title="fpage">1198</span>â€"<span class="lpage" tagx="lpage" title="lpage">1205</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1128/JVI.01248-09">10.1128/JVI.01248-09</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19864379">19864379</a></span></span></li> <li tag="ref"><a name="C20" /><span class="label" tagx="label" title="label">20</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Haga</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yamamoto</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nakai-Murakami</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Modulation of TNF-Î±-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-Î± production and facilitates viral entry</span>. <span class="source" tagx="source" title="source">Proc Natl Acad Sci U S A</span><span class="year" tagx="year" title="year">2008</span>; <span class="volume" tagx="volume" title="volume">105</span>: <span class="fpage" tagx="fpage" title="fpage">7809</span>â€"<span class="lpage" tagx="lpage" title="lpage">7814</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1073/pnas.0711241105">10.1073/pnas.0711241105</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18490652">18490652</a></span></span></li> <li tag="ref"><a name="C21" /><span class="label" tagx="label" title="label">21</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">DP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lohani</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cho</span><span class="given-names" tagx="given-names" title="given-names">MW</span></span></span><span class="mixed-article-title" title="mixed-article-title">Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry</span>. <span class="source" tagx="source" title="source">J Virol</span><span class="year" tagx="year" title="year">2007</span>; <span class="volume" tagx="volume" title="volume">81</span>: <span class="fpage" tagx="fpage" title="fpage">12029</span>â€"<span class="lpage" tagx="lpage" title="lpage">12039</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1128/JVI.00315-07">10.1128/JVI.00315-07</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17715238">17715238</a></span></span></li> <li tag="ref"><a name="C22" /><span class="label" tagx="label" title="label">22</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hoffmann</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kleine-Weber</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schroeder</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</span>. <span class="source" tagx="source" title="source">Cell</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">181</span>: <span class="fpage" tagx="fpage" title="fpage">271</span>â€"<span class="lpage" tagx="lpage" title="lpage">280.e8</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.cell.2020.02.052">10.1016/j.cell.2020.02.052</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32142651">32142651</a></span></span></li> <li tag="ref"><a name="C23" /><span class="label" tagx="label" title="label">23</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Imai</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kuba</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rao</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-converting enzyme 2 protects from severe acute lung failure</span>. <span class="source" tagx="source" title="source">Nature</span><span class="year" tagx="year" title="year">2005</span>; <span class="volume" tagx="volume" title="volume">436</span>: <span class="fpage" tagx="fpage" title="fpage">112</span>â€"<span class="lpage" tagx="lpage" title="lpage">116</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/nature03712">10.1038/nature03712</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16001071">16001071</a></span></span></li> <li tag="ref"><a name="C24" /><span class="label" tagx="label" title="label">24</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jia</span><span class="given-names" tagx="given-names" title="given-names">HP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Look</span><span class="given-names" tagx="given-names" title="given-names">DC</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia</span>. <span class="source" tagx="source" title="source">J Virol</span><span class="year" tagx="year" title="year">2005</span>; <span class="volume" tagx="volume" title="volume">79</span>: <span class="fpage" tagx="fpage" title="fpage">14614</span>â€"<span class="lpage" tagx="lpage" title="lpage">14621</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1128/JVI.79.23.14614-14621.2005">10.1128/JVI.79.23.14614-14621.2005</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16282461">16282461</a></span></span></li> <li tag="ref"><a name="C25" /><span class="label" tagx="label" title="label">25</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jia</span><span class="given-names" tagx="given-names" title="given-names">HP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Look</span><span class="given-names" tagx="given-names" title="given-names">DC</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tan</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia</span>. <span class="source" tagx="source" title="source">Am J Physiol Lung Cell Mol Physiol</span><span class="year" tagx="year" title="year">2009</span>; <span class="volume" tagx="volume" title="volume">297</span>: <span class="fpage" tagx="fpage" title="fpage">L84</span>â€"<span class="lpage" tagx="lpage" title="lpage">L96</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1152/ajplung.00071.2009">10.1152/ajplung.00071.2009</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19411314">19411314</a></span></span></li> <li tag="ref"><a name="C26" /><span class="label" tagx="label" title="label">26</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="collab'">collab: CDC</span></span><span class="mixed-article-title" title="mixed-article-title">From the Centers for Disease Control and Prevention. Severe Acute Respiratory Syndrome (SARS) and coronavirus testing--United States, 2003</span>. <span class="source" tagx="source" title="source">JAMA</span><span class="year" tagx="year" title="year">2003</span>; <span class="volume" tagx="volume" title="volume">289</span>: <span class="fpage" tagx="fpage" title="fpage">2203</span>â€"<span class="lpage" tagx="lpage" title="lpage">2206</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1001/jama.289.17.2203">10.1001/jama.289.17.2203</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12734120">12734120</a></span></span></li> <li tag="ref"><a name="C27" /><span class="label" tagx="label" title="label">27</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Wit</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Doremalen</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Falzarano</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">SARS and MERS: recent insights into emerging coronaviruses</span>. <span class="source" tagx="source" title="source">Nat Rev Microbiol</span><span class="year" tagx="year" title="year">2016</span>; <span class="volume" tagx="volume" title="volume">14</span>: <span class="fpage" tagx="fpage" title="fpage">523</span>â€"<span class="lpage" tagx="lpage" title="lpage">534</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/nrmicro.2016.81">10.1038/nrmicro.2016.81</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27344959">27344959</a></span></span></li> <li tag="ref"><a name="C28" /><span class="label" tagx="label" title="label">28</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bao</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">From SARS to MERS, Thrusting Coronaviruses into the Spotlight</span>. <span class="source" tagx="source" title="source">Viruses</span><span class="year" tagx="year" title="year">2019</span>; <span class="volume" tagx="volume" title="volume">11</span>: <span class="fpage" tagx="fpage" title="fpage">59</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.3390/v11010059">10.3390/v11010059</a></span></span></li> <li tag="ref"><a name="C29" /><span class="label" tagx="label" title="label">29</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span></span><span class="mixed-article-title" title="mixed-article-title">Potential interventions for novel coronavirus in China: A systematic review</span>. <span class="source" tagx="source" title="source">J Med Virol</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">92</span>: <span class="fpage" tagx="fpage" title="fpage">479</span>â€"<span class="lpage" tagx="lpage" title="lpage">490</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1002/jmv.25707">10.1002/jmv.25707</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32052466">32052466</a></span></span></li> <li tag="ref"><a name="C30" /><span class="label" tagx="label" title="label">30</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Updated approaches against SARS-CoV-2</span>. <span class="source" tagx="source" title="source">Antimicrob Agents Chemother</span><span class="year" tagx="year" title="year">2020</span><span class="comment">AAC.00483-00420</span>.</span></li> <li tag="ref"><a name="C31" /><span class="label" tagx="label" title="label">31</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nie</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Penny</span><span class="given-names" tagx="given-names" title="given-names">M</span></span></span><span class="mixed-article-title" title="mixed-article-title">Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis</span>. <span class="source" tagx="source" title="source">J Med Virol</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C32" /><span class="label" tagx="label" title="label">32</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wilder-Smith</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Freedman</span><span class="given-names" tagx="given-names" title="given-names">DO</span></span></span><span class="mixed-article-title" title="mixed-article-title">Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak</span>. <span class="source" tagx="source" title="source">J Travel Med</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">27</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1093/jtm/taaa020">10.1093/jtm/taaa020</a></span></span></li> <li tag="ref"><a name="C33" /><span class="label" tagx="label" title="label">33</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gurwitz</span><span class="given-names" tagx="given-names" title="given-names">D</span></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics</span>. <span class="source" tagx="source" title="source">Drug Dev Res</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C34" /><span class="label" tagx="label" title="label">34</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Henry</span><span class="given-names" tagx="given-names" title="given-names">B</span></span></span><span class="comment">COVID-19 induced Reninâ€"Angiotensin System (RAS) imbalance may drive acute lung injury: the evidence and therapeutic options</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C35" /><span class="label" tagx="label" title="label">35</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">ML</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">YP</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia]</span>. <span class="source" tagx="source" title="source">Zhonghua Jie He He Hu Xi Za Zhi</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">43</span>: <span class="fpage" tagx="fpage" title="fpage">E014</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32061198">32061198</a></span></span></li> <li tag="ref"><a name="C36" /><span class="label" tagx="label" title="label">36</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tignanelli</span><span class="given-names" tagx="given-names" title="given-names">CJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ingraham</span><span class="given-names" tagx="given-names" title="given-names">NE</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sparks</span><span class="given-names" tagx="given-names" title="given-names">MA</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Antihypertensive drugs and risk of COVID-19?</span><span class="source" tagx="source" title="source">Lancet Respir Med</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C37" /><span class="label" tagx="label" title="label">37</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="source" tagx="source" title="source">BMJ</span><span class="year" tagx="year" title="year">2020</span>;<span class="volume" tagx="volume" title="volume">368</span>:<span class="fpage" tagx="fpage" title="fpage">m406</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32005675">32005675</a></span></span></li> <li tag="ref"><a name="C38" /><span class="label" tagx="label" title="label">38</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zheng</span><span class="given-names" tagx="given-names" title="given-names">YY</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">YT</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">JY</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">COVID-19 and the cardiovascular system</span>. <span class="source" tagx="source" title="source">Nat Rev Cardiol</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C39" /><span class="label" tagx="label" title="label">39</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sommerstein</span><span class="given-names" tagx="given-names" title="given-names">R</span></span></span><span class="comment">Rapid Response to Preventing a covid-19 pandemic: ACE inhibitors as a potenial risk factor for fatal Covid-19</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C40" /><span class="label" tagx="label" title="label">40</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Garami</span><span class="given-names" tagx="given-names" title="given-names">AR</span></span></span><span class="source" tagx="source" title="source">Rapid response to Preventing a covid-19 pandemic: Is there a magic bullet to save COVID-19 Patients? We can give it a try!</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">British Medical Journal Publishing Group</span>; <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C41" /><span class="label" tagx="label" title="label">41</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghazi</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Drawz</span><span class="given-names" tagx="given-names" title="given-names">P</span></span></span><span class="mixed-article-title" title="mixed-article-title">Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy</span>. <span class="source" tagx="source" title="source">F1000Research</span><span class="year" tagx="year" title="year">2017</span>; <span class="volume" tagx="volume" title="volume">6</span>: <span class="fpage" tagx="fpage" title="fpage">F1000</span>, <span class="comment">Faculty Rev-1297</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.12688/f1000research.9692.1">10.12688/f1000research.9692.1</a></span></span></li> <li tag="ref"><a name="C42" /><span class="label" tagx="label" title="label">42</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tikellis</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Thomas</span><span class="given-names" tagx="given-names" title="given-names">MC</span></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease</span>. <span class="source" tagx="source" title="source">Int J Pept</span><span class="year" tagx="year" title="year">2012</span>; <span class="volume" tagx="volume" title="volume">2012</span>: <span class="fpage" tagx="fpage" title="fpage">256294</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1155/2012/256294">10.1155/2012/256294</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22536270">22536270</a></span></span></li> <li tag="ref"><a name="C43" /><span class="label" tagx="label" title="label">43</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Balakumar</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jagadeesh</span><span class="given-names" tagx="given-names" title="given-names">G</span></span></span><span class="mixed-article-title" title="mixed-article-title">A century old reninâ€"angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology</span>. <span class="source" tagx="source" title="source">Cell Signal</span><span class="year" tagx="year" title="year">2014</span>; <span class="volume" tagx="volume" title="volume">26</span>: <span class="fpage" tagx="fpage" title="fpage">2147</span>â€"<span class="lpage" tagx="lpage" title="lpage">2160</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.cellsig.2014.06.011">10.1016/j.cellsig.2014.06.011</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25007996">25007996</a></span></span></li> <li tag="ref"><a name="C44" /><span class="label" tagx="label" title="label">44</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Strawn</span><span class="given-names" tagx="given-names" title="given-names">WB</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ferrario</span><span class="given-names" tagx="given-names" title="given-names">CM</span></span></span><span class="mixed-article-title" title="mixed-article-title">Mechanisms linking angiotensin II and atherogenesis</span>. <span class="source" tagx="source" title="source">Curr Opin Lipidol</span><span class="year" tagx="year" title="year">2002</span>; <span class="volume" tagx="volume" title="volume">13</span>: <span class="fpage" tagx="fpage" title="fpage">505</span>â€"<span class="lpage" tagx="lpage" title="lpage">512</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1097/00041433-200210000-00006">10.1097/00041433-200210000-00006</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12352014">12352014</a></span></span></li> <li tag="ref"><a name="C45" /><span class="label" tagx="label" title="label">45</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dandona</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dhindsa</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghanim</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade</span>. <span class="source" tagx="source" title="source">J Hum Hypertens</span><span class="year" tagx="year" title="year">2007</span>; <span class="volume" tagx="volume" title="volume">21</span>: <span class="fpage" tagx="fpage" title="fpage">20</span>â€"<span class="lpage" tagx="lpage" title="lpage">27</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/sj.jhh.1002101">10.1038/sj.jhh.1002101</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17096009">17096009</a></span></span></li> <li tag="ref"><a name="C46" /><span class="label" tagx="label" title="label">46</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Warner</span><span class="given-names" tagx="given-names" title="given-names">FJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smith</span><span class="given-names" tagx="given-names" title="given-names">AI</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hooper</span><span class="given-names" tagx="given-names" title="given-names">NM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-converting enzyme-2: a molecular and cellular perspective</span>. <span class="source" tagx="source" title="source">Cell Mol Life Sci</span><span class="year" tagx="year" title="year">2004</span>; <span class="volume" tagx="volume" title="volume">61</span>: <span class="fpage" tagx="fpage" title="fpage">2704</span>â€"<span class="lpage" tagx="lpage" title="lpage">2713</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1007/s00018-004-4240-7">10.1007/s00018-004-4240-7</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15549171">15549171</a></span></span></li> <li tag="ref"><a name="C47" /><span class="label" tagx="label" title="label">47</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baker</span><span class="given-names" tagx="given-names" title="given-names">A</span></span></span><span class="source" tagx="source" title="source">Recombinant human ACE2: acing out angiotensin II in ARDS therapy</span>. <span class="publisher-name" tagx="publisher-name" title="publisher-name">Springer</span>, <span class="year" tagx="year" title="year">2017</span>.</span></li> <li tag="ref"><a name="C48" /><span class="label" tagx="label" title="label">48</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin II aggravates lipopolysaccharide induced human pulmonary microvascular endothelial cells permeability in high glucose status</span>. <span class="source" tagx="source" title="source">Endocr J</span><span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">65</span>: <span class="fpage" tagx="fpage" title="fpage">717</span>â€"<span class="lpage" tagx="lpage" title="lpage">725</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1507/endocrj.EJ17-0477">10.1507/endocrj.EJ17-0477</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29709898">29709898</a></span></span></li> <li tag="ref"><a name="C49" /><span class="label" tagx="label" title="label">49</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Filippatos</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Uhal</span><span class="given-names" tagx="given-names" title="given-names">BD</span></span></span><span class="mixed-article-title" title="mixed-article-title">Blockade of apoptosis by ACE inhibitors and angiotensin receptor antagonists</span>. <span class="source" tagx="source" title="source">Curr Pharm Des</span><span class="year" tagx="year" title="year">2003</span>; <span class="volume" tagx="volume" title="volume">9</span>: <span class="fpage" tagx="fpage" title="fpage">707</span>â€"<span class="lpage" tagx="lpage" title="lpage">714</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.2174/1381612033455477">10.2174/1381612033455477</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12570788">12570788</a></span></span></li> <li tag="ref"><a name="C50" /><span class="label" tagx="label" title="label">50</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wosten-van Asperen</span><span class="given-names" tagx="given-names" title="given-names">RM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lutter</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Specht</span><span class="given-names" tagx="given-names" title="given-names">PA</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist</span>. <span class="source" tagx="source" title="source">J Pathol</span><span class="year" tagx="year" title="year">2011</span>; <span class="volume" tagx="volume" title="volume">225</span>: <span class="fpage" tagx="fpage" title="fpage">618</span>â€"<span class="lpage" tagx="lpage" title="lpage">627</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1002/path.2987">10.1002/path.2987</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22009550">22009550</a></span></span></li> <li tag="ref"><a name="C51" /><span class="label" tagx="label" title="label">51</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Raiden</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nahmod</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nahmod</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome</span>. <span class="source" tagx="source" title="source">J Pharmacol Exp Ther</span><span class="year" tagx="year" title="year">2002</span>; <span class="volume" tagx="volume" title="volume">303</span>: <span class="fpage" tagx="fpage" title="fpage">45</span>â€"<span class="lpage" tagx="lpage" title="lpage">51</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1124/jpet.102.037382">10.1124/jpet.102.037382</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12235231">12235231</a></span></span></li> <li tag="ref"><a name="C52" /><span class="label" tagx="label" title="label">52</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mossel</span><span class="given-names" tagx="given-names" title="given-names">EC</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeffers</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells</span>. <span class="source" tagx="source" title="source">Virology</span><span class="year" tagx="year" title="year">2008</span>; <span class="volume" tagx="volume" title="volume">372</span>: <span class="fpage" tagx="fpage" title="fpage">127</span>â€"<span class="lpage" tagx="lpage" title="lpage">135</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.virol.2007.09.045">10.1016/j.virol.2007.09.045</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18022664">18022664</a></span></span></li> <li tag="ref"><a name="C53" /><span class="label" tagx="label" title="label">53</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turner</span><span class="given-names" tagx="given-names" title="given-names">AJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hiscox</span><span class="given-names" tagx="given-names" title="given-names">JA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hooper</span><span class="given-names" tagx="given-names" title="given-names">NM</span></span></span><span class="mixed-article-title" title="mixed-article-title">ACE2: from vasopeptidase to SARS virus receptor</span>. <span class="source" tagx="source" title="source">Trends Pharmacol Sci</span><span class="year" tagx="year" title="year">2004</span>; <span class="volume" tagx="volume" title="volume">25</span>: <span class="fpage" tagx="fpage" title="fpage">291</span>â€"<span class="lpage" tagx="lpage" title="lpage">294</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.tips.2004.04.001">10.1016/j.tips.2004.04.001</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15165741">15165741</a></span></span></li> <li tag="ref"><a name="C54" /><span class="label" tagx="label" title="label">54</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramchand</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Patel</span><span class="given-names" tagx="given-names" title="given-names">SK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Srivastava</span><span class="given-names" tagx="given-names" title="given-names">PM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease</span>. <span class="source" tagx="source" title="source">PLoS One</span><span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">13</span>: <span class="fpage" tagx="fpage" title="fpage">e0198144</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1371/journal.pone.0198144">10.1371/journal.pone.0198144</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29897923">29897923</a></span></span></li> <li tag="ref"><a name="C55" /><span class="label" tagx="label" title="label">55</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">AlGhatrif</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cingolani</span><span class="given-names" tagx="given-names" title="given-names">O</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lakatta</span><span class="given-names" tagx="given-names" title="given-names">EG</span></span></span><span class="mixed-article-title" title="mixed-article-title">The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science</span>. <span class="source" tagx="source" title="source">JAMA Cardiol</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C56" /><span class="label" tagx="label" title="label">56</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Campbell</span><span class="given-names" tagx="given-names" title="given-names">DJ</span></span></span><span class="mixed-article-title" title="mixed-article-title">Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists</span>. <span class="source" tagx="source" title="source">Clin Exp Pharmacol Physiol Suppl</span><span class="year" tagx="year" title="year">1996</span>; <span class="volume" tagx="volume" title="volume">3</span>: <span class="fpage" tagx="fpage" title="fpage">S125</span>â€"<span class="lpage" tagx="lpage" title="lpage">S131</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1440-1681.1996.tb03073.x">10.1111/j.1440-1681.1996.tb03073.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8993851">8993851</a></span></span></li> <li tag="ref"><a name="C57" /><span class="label" tagx="label" title="label">57</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hollenberg</span><span class="given-names" tagx="given-names" title="given-names">NK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fisher</span><span class="given-names" tagx="given-names" title="given-names">ND</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Price</span><span class="given-names" tagx="given-names" title="given-names">DA</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system</span>. <span class="source" tagx="source" title="source">Hypertension</span><span class="year" tagx="year" title="year">1998</span>; <span class="volume" tagx="volume" title="volume">32</span>: <span class="fpage" tagx="fpage" title="fpage">387</span>â€"<span class="lpage" tagx="lpage" title="lpage">392</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1161/01.HYP.32.3.387">10.1161/01.HYP.32.3.387</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9740600">9740600</a></span></span></li> <li tag="ref"><a name="C58" /><span class="label" tagx="label" title="label">58</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schunkert</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ingelfinger</span><span class="given-names" tagx="given-names" title="given-names">JR</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hirsch</span><span class="given-names" tagx="given-names" title="given-names">AT</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II</span>. <span class="source" tagx="source" title="source">Circ Res</span><span class="year" tagx="year" title="year">1993</span>; <span class="volume" tagx="volume" title="volume">72</span>: <span class="fpage" tagx="fpage" title="fpage">312</span>â€"<span class="lpage" tagx="lpage" title="lpage">318</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1161/01.RES.72.2.312">10.1161/01.RES.72.2.312</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8380358">8380358</a></span></span></li> <li tag="ref"><a name="C59" /><span class="label" tagx="label" title="label">59</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jurado-Palomo</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Caballero</span><span class="given-names" tagx="given-names" title="given-names">T</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pathophysiology of Bradykinin-Mediated Angioedema: The Role of the Complement System</span>. <span class="conf-name" tagx="conf-name" title="conf-name">A Comprehensive Review of Urticaria and Angioedema Selda Pelin Kartal &amp;amp; Zekayi Kutlubay (Eds) Intech Open Access Publisher (Rijeka-Croatia)</span><span class="year" tagx="year" title="year">2017</span>; pp. <span class="fpage" tagx="fpage" title="fpage">151</span>â€"<span class="lpage" tagx="lpage" title="lpage">176</span>.</span></li> <li tag="ref"><a name="C60" /><span class="label" tagx="label" title="label">60</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bahat</span><span class="given-names" tagx="given-names" title="given-names">G</span></span></span><span class="comment">Angiotensin converting enzyme (ACE) inhibition may have a role in the symptoms and progression of COVID-19 infection</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C61" /><span class="label" tagx="label" title="label">61</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van de Veerdonk</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Netea</span><span class="given-names" tagx="given-names" title="given-names">MG</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Deuren</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Kinins and Cytokines in COVID-19: A Comprehensive Pathophysiological Approach (Preprint)</span>. <span class="source" tagx="source" title="source">Preprints</span><span class="year" tagx="year" title="year">2020</span>: <span class="fpage" tagx="fpage" title="fpage">2020040023</span>. doi: <span class="pub-id"><a href="https://dx.doi.org/10.20944/preprints202004.0023.v1">10.20944/preprints202004.0023.v1</a></span>.</span></li> <li tag="ref"><a name="C62" /><span class="label" tagx="label" title="label">62</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Braun-Menendez</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fasciolo</span><span class="given-names" tagx="given-names" title="given-names">JC</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leloir</span><span class="given-names" tagx="given-names" title="given-names">LF</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">The substance causing renal hypertension</span>. <span class="source" tagx="source" title="source">J Physiol</span><span class="year" tagx="year" title="year">1940</span>; <span class="volume" tagx="volume" title="volume">98</span>: <span class="fpage" tagx="fpage" title="fpage">283</span>â€"<span class="lpage" tagx="lpage" title="lpage">298</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1113/jphysiol.1940.sp003850">10.1113/jphysiol.1940.sp003850</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16995204">16995204</a></span></span></li> <li tag="ref"><a name="C63" /><span class="label" tagx="label" title="label">63</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Walters</span><span class="given-names" tagx="given-names" title="given-names">TE</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalman</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Patel</span><span class="given-names" tagx="given-names" title="given-names">SK</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling</span>. <span class="source" tagx="source" title="source">Europace</span><span class="year" tagx="year" title="year">2017</span>; <span class="volume" tagx="volume" title="volume">19</span>: <span class="fpage" tagx="fpage" title="fpage">1280</span>â€"<span class="lpage" tagx="lpage" title="lpage">1287</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27738071">27738071</a></span></span></li> <li tag="ref"><a name="C64" /><span class="label" tagx="label" title="label">64</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turner</span><span class="given-names" tagx="given-names" title="given-names">AJ</span></span></span><span class="chapter-title" tagx="chapter-title" title="chapter-title">ACE2 Cell Biology, Regulation, and Physiological Functions</span><i>In</i>: <span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Unger</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Steckelings</span><span class="given-names" tagx="given-names" title="given-names">UM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">dos Santos</span><span class="given-names" tagx="given-names" title="given-names">RAS</span></span></span>, eds. <span class="source" tagx="source" title="source">The Protective Arm of the Renin Angiotensin System (RAS)</span>. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Boston</span>, <span class="publisher-name" tagx="publisher-name" title="publisher-name">Academic Press</span>, <span class="year" tagx="year" title="year">2015</span>; pp. <span class="fpage" tagx="fpage" title="fpage">185</span>â€"<span class="lpage" tagx="lpage" title="lpage">189</span>.</span></li> <li tag="ref"><a name="C65" /><span class="label" tagx="label" title="label">65</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Crackower</span><span class="given-names" tagx="given-names" title="given-names">MA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sarao</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oudit</span><span class="given-names" tagx="given-names" title="given-names">GY</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-converting enzyme 2 is an essential regulator of heart function</span>. <span class="source" tagx="source" title="source">Nature</span><span class="year" tagx="year" title="year">2002</span>; <span class="volume" tagx="volume" title="volume">417</span>: <span class="fpage" tagx="fpage" title="fpage">822</span>â€"<span class="lpage" tagx="lpage" title="lpage">828</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/nature00786">10.1038/nature00786</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12075344">12075344</a></span></span></li> <li tag="ref"><a name="C66" /><span class="label" tagx="label" title="label">66</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rentzsch</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Todiras</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Iliescu</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function</span>. <span class="source" tagx="source" title="source">Hypertension</span><span class="year" tagx="year" title="year">2008</span>; <span class="volume" tagx="volume" title="volume">52</span>: <span class="fpage" tagx="fpage" title="fpage">967</span>â€"<span class="lpage" tagx="lpage" title="lpage">973</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1161/HYPERTENSIONAHA.108.114322">10.1161/HYPERTENSIONAHA.108.114322</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18809792">18809792</a></span></span></li> <li tag="ref"><a name="C67" /><span class="label" tagx="label" title="label">67</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turner</span><span class="given-names" tagx="given-names" title="given-names">AJ</span></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-converting enzyme 2: cardioprotective player in the renin-angiotensin system?</span><span class="source" tagx="source" title="source">Am Heart Assoc</span><span class="year" tagx="year" title="year">2008</span>.</span></li> <li tag="ref"><a name="C68" /><span class="label" tagx="label" title="label">68</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ferrario</span><span class="given-names" tagx="given-names" title="given-names">CM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jessup</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chappell</span><span class="given-names" tagx="given-names" title="given-names">MC</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2</span>. <span class="source" tagx="source" title="source">Circulation</span><span class="year" tagx="year" title="year">2005</span>; <span class="volume" tagx="volume" title="volume">111</span>: <span class="fpage" tagx="fpage" title="fpage">2605</span>â€"<span class="lpage" tagx="lpage" title="lpage">2610</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1161/CIRCULATIONAHA.104.510461">10.1161/CIRCULATIONAHA.104.510461</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15897343">15897343</a></span></span></li> <li tag="ref"><a name="C69" /><span class="label" tagx="label" title="label">69</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ocaranza</span><span class="given-names" tagx="given-names" title="given-names">MP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Godoy</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jalil</span><span class="given-names" tagx="given-names" title="given-names">JE</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat</span>. <span class="source" tagx="source" title="source">Hypertension</span><span class="year" tagx="year" title="year">2006</span>; <span class="volume" tagx="volume" title="volume">48</span>: <span class="fpage" tagx="fpage" title="fpage">572</span>â€"<span class="lpage" tagx="lpage" title="lpage">578</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1161/01.HYP.0000237862.94083.45">10.1161/01.HYP.0000237862.94083.45</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16908757">16908757</a></span></span></li> <li tag="ref"><a name="C70" /><span class="label" tagx="label" title="label">70</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perlot</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Penninger</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span></span><span class="mixed-article-title" title="mixed-article-title">ACE2 - from the renin-angiotensin system to gut microbiota and malnutrition</span>. <span class="source" tagx="source" title="source">Microbes Infect</span><span class="year" tagx="year" title="year">2013</span>; <span class="volume" tagx="volume" title="volume">15</span>: <span class="fpage" tagx="fpage" title="fpage">866</span>â€"<span class="lpage" tagx="lpage" title="lpage">873</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.micinf.2013.08.003">10.1016/j.micinf.2013.08.003</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23962453">23962453</a></span></span></li> <li tag="ref"><a name="C71" /><span class="label" tagx="label" title="label">71</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Hypokalemia and Clinical Implications in Patients with Coronavirus Disease 2019 (COVID-19)</span>. <span class="source" tagx="source" title="source">medRxiv</span><span class="year" tagx="year" title="year">2020</span><span class="comment">2020.2002.2027.20028530</span>.</span></li> <li tag="ref"><a name="C72" /><span class="label" tagx="label" title="label">72</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lai</span><span class="given-names" tagx="given-names" title="given-names">CC</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">YH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">CY</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD</span>. <span class="source" tagx="source" title="source">Int J Chron Obstruct Pulmon Dis</span><span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">13</span>: <span class="fpage" tagx="fpage" title="fpage">867</span>â€"<span class="lpage" tagx="lpage" title="lpage">874</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.2147/COPD.S158634">10.2147/COPD.S158634</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29563786">29563786</a></span></span></li> <li tag="ref"><a name="C73" /><span class="label" tagx="label" title="label">73</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mortensen</span><span class="given-names" tagx="given-names" title="given-names">EM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nakashima</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cornell</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes</span>. <span class="source" tagx="source" title="source">Clin Infect Dis</span><span class="year" tagx="year" title="year">2012</span>; <span class="volume" tagx="volume" title="volume">55</span>: <span class="fpage" tagx="fpage" title="fpage">1466</span>â€"<span class="lpage" tagx="lpage" title="lpage">1473</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1093/cid/cis733">10.1093/cid/cis733</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22918991">22918991</a></span></span></li> <li tag="ref"><a name="C74" /><span class="label" tagx="label" title="label">74</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Deshotels</span><span class="given-names" tagx="given-names" title="given-names">MR</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sriramula</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin ii type i receptorâ€"dependent mechanism</span>. <span class="source" tagx="source" title="source">Hypertension</span><span class="year" tagx="year" title="year">2014</span>; <span class="volume" tagx="volume" title="volume">64</span>: <span class="fpage" tagx="fpage" title="fpage">1368</span>â€"<span class="lpage" tagx="lpage" title="lpage">1375</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1161/HYPERTENSIONAHA.114.03743">10.1161/HYPERTENSIONAHA.114.03743</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25225202">25225202</a></span></span></li> <li tag="ref"><a name="C75" /><span class="label" tagx="label" title="label">75</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tao</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">PS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Soluble Epoxide Hydrolase Plays a Vital Role in Angiotensin II-Induced Lung Injury in Mice</span>. <span class="source" tagx="source" title="source">Shock</span><span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">50</span>: <span class="fpage" tagx="fpage" title="fpage">589</span>â€"<span class="lpage" tagx="lpage" title="lpage">594</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1097/SHK.0000000000001067">10.1097/SHK.0000000000001067</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29206762">29206762</a></span></span></li> <li tag="ref"><a name="C76" /><span class="label" tagx="label" title="label">76</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Losartan attenuates microvascular permeability in mechanical ventilator-induced lung injury in diabetic mice</span>. <span class="source" tagx="source" title="source">Mol Biol Rep</span><span class="year" tagx="year" title="year">2014</span>; <span class="volume" tagx="volume" title="volume">41</span>: <span class="fpage" tagx="fpage" title="fpage">809</span>â€"<span class="lpage" tagx="lpage" title="lpage">814</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1007/s11033-013-2920-9">10.1007/s11033-013-2920-9</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24420847">24420847</a></span></span></li> <li tag="ref"><a name="C77" /><span class="label" tagx="label" title="label">77</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yao</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feng</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Losartan attenuates ventilator-induced lung injury</span>. <span class="source" tagx="source" title="source">J Surg Res</span><span class="year" tagx="year" title="year">2008</span>; <span class="volume" tagx="volume" title="volume">145</span>: <span class="fpage" tagx="fpage" title="fpage">25</span>â€"<span class="lpage" tagx="lpage" title="lpage">32</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jss.2007.03.075">10.1016/j.jss.2007.03.075</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17688881">17688881</a></span></span></li> <li tag="ref"><a name="C78" /><span class="label" tagx="label" title="label">78</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ling</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lou</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">[Losartan regulates oxidative stress via caveolin-1 and NOX4 in mice with ventilator- induced lung injury]</span>. <span class="source" tagx="source" title="source">Nan Fang Yi Ke Da Xue Xue Bao</span><span class="year" tagx="year" title="year">2015</span>; <span class="volume" tagx="volume" title="volume">35</span>: <span class="fpage" tagx="fpage" title="fpage">1739</span>â€"<span class="lpage" tagx="lpage" title="lpage">1744</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26714908">26714908</a></span></span></li> <li tag="ref"><a name="C79" /><span class="label" tagx="label" title="label">79</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Adamzik</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Frey</span><span class="given-names" tagx="given-names" title="given-names">U</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sixt</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">ACE I/D but not AGT (-6) A/G polymorphism is a risk factor for mortality in ARDS</span>. <span class="source" tagx="source" title="source">Eur Respir J</span><span class="year" tagx="year" title="year">2007</span>; <span class="volume" tagx="volume" title="volume">29</span>: <span class="fpage" tagx="fpage" title="fpage">482</span>â€"<span class="lpage" tagx="lpage" title="lpage">488</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1183/09031936.00046106">10.1183/09031936.00046106</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17107992">17107992</a></span></span></li> <li tag="ref"><a name="C80" /><span class="label" tagx="label" title="label">80</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Choi</span><span class="given-names" tagx="given-names" title="given-names">SM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Effect of Renin-Angiotensin System Blockage in Patients with Acute Respiratory Distress Syndrome: A Retrospective Case Control Study</span>. <span class="source" tagx="source" title="source">Korean J Crit Care Med</span><span class="year" tagx="year" title="year">2017</span>; <span class="volume" tagx="volume" title="volume">32</span>: <span class="fpage" tagx="fpage" title="fpage">154</span>â€"<span class="lpage" tagx="lpage" title="lpage">163</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.4266/kjccm.2016.00976">10.4266/kjccm.2016.00976</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31723629">31723629</a></span></span></li> <li tag="ref"><a name="C81" /><span class="label" tagx="label" title="label">81</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Noveanu</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Breidthardt</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reichlin</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Effect of oral beta-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study</span>. <span class="source" tagx="source" title="source">Crit Care</span><span class="year" tagx="year" title="year">2010</span>; <span class="volume" tagx="volume" title="volume">14</span>: <span class="fpage" tagx="fpage" title="fpage">R198</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1186/cc9317">10.1186/cc9317</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21047406">21047406</a></span></span></li> <li tag="ref"><a name="C82" /><span class="label" tagx="label" title="label">82</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hsieh</span><span class="given-names" tagx="given-names" title="given-names">M-S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">How</span><span class="given-names" tagx="given-names" title="given-names">C-K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hsieh</span><span class="given-names" tagx="given-names" title="given-names">VC-R</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Preadmission antihypertensive drug use and sepsis outcome: impact of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs)</span>. <span class="source" tagx="source" title="source">Shock</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">53</span>: <span class="fpage" tagx="fpage" title="fpage">407</span>â€"<span class="lpage" tagx="lpage" title="lpage">415</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1097/SHK.0000000000001382">10.1097/SHK.0000000000001382</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31135703">31135703</a></span></span></li> <li tag="ref"><a name="C83" /><span class="label" tagx="label" title="label">83</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mortensen</span><span class="given-names" tagx="given-names" title="given-names">EM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Restrepo</span><span class="given-names" tagx="given-names" title="given-names">MI</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Copeland</span><span class="given-names" tagx="given-names" title="given-names">LA</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis</span>. <span class="source" tagx="source" title="source">Pharmacotherapy</span><span class="year" tagx="year" title="year">2007</span>; <span class="volume" tagx="volume" title="volume">27</span>: <span class="fpage" tagx="fpage" title="fpage">1619</span>â€"<span class="lpage" tagx="lpage" title="lpage">1626</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1592/phco.27.12.1619">10.1592/phco.27.12.1619</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18041882">18041882</a></span></span></li> <li tag="ref"><a name="C84" /><span class="label" tagx="label" title="label">84</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boyle</span><span class="given-names" tagx="given-names" title="given-names">AJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mac Sweeney</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McAuley</span><span class="given-names" tagx="given-names" title="given-names">DF</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pharmacological treatments in ARDS; a state-of-the-art update</span>. <span class="source" tagx="source" title="source">BMC Med</span><span class="year" tagx="year" title="year">2013</span>; <span class="volume" tagx="volume" title="volume">11</span>: <span class="fpage" tagx="fpage" title="fpage">166</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1186/1741-7015-11-166">10.1186/1741-7015-11-166</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23957905">23957905</a></span></span></li> <li tag="ref"><a name="C85" /><span class="label" tagx="label" title="label">85</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zou</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients</span>. <span class="source" tagx="source" title="source">Nat Commun</span><span class="year" tagx="year" title="year">2014</span>; <span class="volume" tagx="volume" title="volume">5</span>: <span class="fpage" tagx="fpage" title="fpage">3595</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/ncomms4595">10.1038/ncomms4595</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24800963">24800963</a></span></span></li> <li tag="ref"><a name="C86" /><span class="label" tagx="label" title="label">86</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Henry</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zaizafoun</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stock</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia</span>. In: <span class="conf-name" tagx="conf-name" title="conf-name">Baylor University Medical Center Proceedings: 2018: Taylor &amp;amp; Francis</span>; <span class="year" tagx="year" title="year">2018</span>, pp. <span class="fpage" tagx="fpage" title="fpage">419</span>â€"<span class="lpage" tagx="lpage" title="lpage">423</span>.</span></li> <li tag="ref"><a name="C87" /><span class="label" tagx="label" title="label">87</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gu</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xie</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus</span>. <span class="source" tagx="source" title="source">Sci Rep</span><span class="year" tagx="year" title="year">2016</span>; <span class="volume" tagx="volume" title="volume">6</span>: <span class="fpage" tagx="fpage" title="fpage">19840</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/srep19840">10.1038/srep19840</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26813885">26813885</a></span></span></li> <li tag="ref"><a name="C88" /><span class="label" tagx="label" title="label">88</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zou</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections</span>. <span class="source" tagx="source" title="source">Nat Commun</span><span class="year" tagx="year" title="year">2014</span>; <span class="volume" tagx="volume" title="volume">5</span>: <span class="fpage" tagx="fpage" title="fpage">3594</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/ncomms4594">10.1038/ncomms4594</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24800825">24800825</a></span></span></li> <li tag="ref"><a name="C89" /><span class="label" tagx="label" title="label">89</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gu</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury</span>. <span class="source" tagx="source" title="source">Sci Rep</span><span class="year" tagx="year" title="year">2014</span>; <span class="volume" tagx="volume" title="volume">4</span>: <span class="fpage" tagx="fpage" title="fpage">7027</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/srep07027">10.1038/srep07027</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25391767">25391767</a></span></span></li> <li tag="ref"><a name="C90" /><span class="label" tagx="label" title="label">90</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse</span>. <span class="source" tagx="source" title="source">Sci China Life Sci</span><span class="year" tagx="year" title="year">2015</span>; <span class="volume" tagx="volume" title="volume">58</span>: <span class="fpage" tagx="fpage" title="fpage">208</span>â€"<span class="lpage" tagx="lpage" title="lpage">211</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1007/s11427-015-4814-7">10.1007/s11427-015-4814-7</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25655897">25655897</a></span></span></li> <li tag="ref"><a name="C91" /><span class="label" tagx="label" title="label">91</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">[Effects of losartan on pulmonary dendritic cells in lipopolysaccharide- induced acute lung injury mice]</span>. <span class="source" tagx="source" title="source">Zhonghua Yi Xue Za Zhi</span><span class="year" tagx="year" title="year">2014</span>; <span class="volume" tagx="volume" title="volume">94</span>: <span class="fpage" tagx="fpage" title="fpage">3216</span>â€"<span class="lpage" tagx="lpage" title="lpage">3219</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25604220">25604220</a></span></span></li> <li tag="ref"><a name="C92" /><span class="label" tagx="label" title="label">92</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Raiden</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pereyra</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nahmod</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits neutrophil recruitment in the lung triggered by fMLP</span>. <span class="source" tagx="source" title="source">J Leukoc Biol</span><span class="year" tagx="year" title="year">2000</span>; <span class="volume" tagx="volume" title="volume">68</span>: <span class="fpage" tagx="fpage" title="fpage">700</span>â€"<span class="lpage" tagx="lpage" title="lpage">706</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11073110">11073110</a></span></span></li> <li tag="ref"><a name="C93" /><span class="label" tagx="label" title="label">93</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schoeman</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fielding</span><span class="given-names" tagx="given-names" title="given-names">BC</span></span></span><span class="mixed-article-title" title="mixed-article-title">Coronavirus envelope protein: current knowledge</span>. <span class="source" tagx="source" title="source">Virol J</span><span class="year" tagx="year" title="year">2019</span>; <span class="volume" tagx="volume" title="volume">16</span>: <span class="fpage" tagx="fpage" title="fpage">69</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1186/s12985-019-1182-0">10.1186/s12985-019-1182-0</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31133031">31133031</a></span></span></li> <li tag="ref"><a name="C94" /><span class="label" tagx="label" title="label">94</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2</span>. <span class="source" tagx="source" title="source">Virus Res</span><span class="year" tagx="year" title="year">2008</span>; <span class="volume" tagx="volume" title="volume">136</span>: <span class="fpage" tagx="fpage" title="fpage">8</span>â€"<span class="lpage" tagx="lpage" title="lpage">15</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.virusres.2008.03.004">10.1016/j.virusres.2008.03.004</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18554741">18554741</a></span></span></li> <li tag="ref"><a name="C95" /><span class="label" tagx="label" title="label">95</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jerng</span><span class="given-names" tagx="given-names" title="given-names">JS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">CJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">HC</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome</span>. <span class="source" tagx="source" title="source">Crit Care Med</span><span class="year" tagx="year" title="year">2006</span>; <span class="volume" tagx="volume" title="volume">34</span>: <span class="fpage" tagx="fpage" title="fpage">1001</span>â€"<span class="lpage" tagx="lpage" title="lpage">1006</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1097/01.CCM.0000206107.92476.39">10.1097/01.CCM.0000206107.92476.39</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16484896">16484896</a></span></span></li> <li tag="ref"><a name="C96" /><span class="label" tagx="label" title="label">96</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury</span>. <span class="source" tagx="source" title="source">Sci China Life Sci</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">63</span>: <span class="fpage" tagx="fpage" title="fpage">364</span>â€"<span class="lpage" tagx="lpage" title="lpage">374</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1007/s11427-020-1643-8">10.1007/s11427-020-1643-8</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32048163">32048163</a></span></span></li> <li tag="ref"><a name="C97" /><span class="label" tagx="label" title="label">97</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</span>. <span class="source" tagx="source" title="source">Lancet</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">395</span>: <span class="fpage" tagx="fpage" title="fpage">1054</span>â€"<span class="lpage" tagx="lpage" title="lpage">1062</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/S0140-6736(20)30566-3">10.1016/S0140-6736(20)30566-3</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32171076">32171076</a></span></span></li> <li tag="ref"><a name="C98" /><span class="label" tagx="label" title="label">98</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xudong</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Junzhu</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xingxiang</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Age-and gender-related difference of ACE2 expression in rat lung</span>. <span class="source" tagx="source" title="source">Life Sci</span><span class="year" tagx="year" title="year">2006</span>; <span class="volume" tagx="volume" title="volume">78</span>: <span class="fpage" tagx="fpage" title="fpage">2166</span>â€"<span class="lpage" tagx="lpage" title="lpage">2171</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.lfs.2005.09.038">10.1016/j.lfs.2005.09.038</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16303146">16303146</a></span></span></li> <li tag="ref"><a name="C99" /><span class="label" tagx="label" title="label">99</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cai</span><span class="given-names" tagx="given-names" title="given-names">H</span></span></span><span class="mixed-article-title" title="mixed-article-title">Sex difference and smoking predisposition in patients with COVID-19</span>. <span class="source" tagx="source" title="source">Lancet Respir Med</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">8</span>: <span class="fpage" tagx="fpage" title="fpage">e20</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/S2213-2600(20)30117-X">10.1016/S2213-2600(20)30117-X</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32171067">32171067</a></span></span></li> <li tag="ref"><a name="C100" /><span class="label" tagx="label" title="label">100</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hilliard</span><span class="given-names" tagx="given-names" title="given-names">LM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jones</span><span class="given-names" tagx="given-names" title="given-names">ES</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Steckelings</span><span class="given-names" tagx="given-names" title="given-names">UM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertension</span>. <span class="source" tagx="source" title="source">Hypertension</span><span class="year" tagx="year" title="year">2012</span>; <span class="volume" tagx="volume" title="volume">59</span>: <span class="fpage" tagx="fpage" title="fpage">409</span>â€"<span class="lpage" tagx="lpage" title="lpage">414</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1161/HYPERTENSIONAHA.111.184986">10.1161/HYPERTENSIONAHA.111.184986</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22158645">22158645</a></span></span></li> <li tag="ref"><a name="C101" /><span class="label" tagx="label" title="label">101</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Packer</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McMurray</span><span class="given-names" tagx="given-names" title="given-names">JJV</span></span></span><span class="mixed-article-title" title="mixed-article-title">Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure</span>. <span class="source" tagx="source" title="source">Lancet</span><span class="year" tagx="year" title="year">2017</span>; <span class="volume" tagx="volume" title="volume">389</span>: <span class="fpage" tagx="fpage" title="fpage">1831</span>â€"<span class="lpage" tagx="lpage" title="lpage">1840</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/S0140-6736(16)30969-2">10.1016/S0140-6736(16)30969-2</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27919443">27919443</a></span></span></li> <li tag="ref"><a name="C102" /><span class="label" tagx="label" title="label">102</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Podowski</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Calvi</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Metzger</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice</span>. <span class="source" tagx="source" title="source">J Clin Invest</span><span class="year" tagx="year" title="year">2012</span>; <span class="volume" tagx="volume" title="volume">122</span>: <span class="fpage" tagx="fpage" title="fpage">229</span>â€"<span class="lpage" tagx="lpage" title="lpage">240</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1172/JCI46215">10.1172/JCI46215</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22182843">22182843</a></span></span></li> <li tag="ref"><a name="C103" /><span class="label" tagx="label" title="label">103</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leung</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">CX</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tam</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19</span>. <span class="source" tagx="source" title="source">Eur Respir J</span><span class="year" tagx="year" title="year">2020</span>: <span class="fpage" tagx="fpage" title="fpage">2000688</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1183/13993003.00688-2020">10.1183/13993003.00688-2020</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32269089">32269089</a></span></span></li> <li tag="ref"><a name="C104" /><span class="label" tagx="label" title="label">104</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yilin</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yandong</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Faguang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span></span><span class="mixed-article-title" title="mixed-article-title">Role of angiotensin-converting enzyme (ACE) and ACE2 in a rat model of smoke inhalation induced acute respiratory distress syndrome</span>. <span class="source" tagx="source" title="source">Burns</span><span class="year" tagx="year" title="year">2015</span>; <span class="volume" tagx="volume" title="volume">41</span>: <span class="fpage" tagx="fpage" title="fpage">1468</span>â€"<span class="lpage" tagx="lpage" title="lpage">1477</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.burns.2015.04.010">10.1016/j.burns.2015.04.010</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25981293">25981293</a></span></span></li> <li tag="ref"><a name="C105" /><span class="label" tagx="label" title="label">105</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fang</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Karakiulakis</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Roth</span><span class="given-names" tagx="given-names" title="given-names">M</span></span></span><span class="mixed-article-title" title="mixed-article-title">Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?</span><span class="source" tagx="source" title="source">Lancet Respir Med</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">8</span>: <span class="fpage" tagx="fpage" title="fpage">e21</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/S2213-2600(20)30116-8">10.1016/S2213-2600(20)30116-8</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32171062">32171062</a></span></span></li> <li tag="ref"><a name="C106" /><span class="label" tagx="label" title="label">106</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Burrell</span><span class="given-names" tagx="given-names" title="given-names">LM</span></span></span><span class="mixed-article-title" title="mixed-article-title">A risk-benefit assessment of losartan potassium in the treatment of hypertension</span>. <span class="source" tagx="source" title="source">Drug Saf</span><span class="year" tagx="year" title="year">1997</span>; <span class="volume" tagx="volume" title="volume">16</span>: <span class="fpage" tagx="fpage" title="fpage">56</span>â€"<span class="lpage" tagx="lpage" title="lpage">65</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.2165/00002018-199716010-00004">10.2165/00002018-199716010-00004</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9010643">9010643</a></span></span></li> <li tag="ref"><a name="C107" /><span class="label" tagx="label" title="label">107</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Christen</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Waeber</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nussberger</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II</span>. <span class="source" tagx="source" title="source">Circulation</span><span class="year" tagx="year" title="year">1991</span>; <span class="volume" tagx="volume" title="volume">83</span>: <span class="fpage" tagx="fpage" title="fpage">1333</span>â€"<span class="lpage" tagx="lpage" title="lpage">1342</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1161/01.CIR.83.4.1333">10.1161/01.CIR.83.4.1333</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2013151">2013151</a></span></span></li> <li tag="ref"><a name="C108" /><span class="label" tagx="label" title="label">108</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Doig</span><span class="given-names" tagx="given-names" title="given-names">JK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MacFadyen</span><span class="given-names" tagx="given-names" title="given-names">RJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sweet</span><span class="given-names" tagx="given-names" title="given-names">CS</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Haemodynamic and renal responses to oral losartan potassium during salt depletion or salt repletion in normal human volunteers</span>. <span class="source" tagx="source" title="source">J Cardiovasc Pharmacol</span><span class="year" tagx="year" title="year">1995</span>; <span class="volume" tagx="volume" title="volume">25</span>: <span class="fpage" tagx="fpage" title="fpage">511</span>â€"<span class="lpage" tagx="lpage" title="lpage">517</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1097/00005344-199504000-00001">10.1097/00005344-199504000-00001</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/7596116">7596116</a></span></span></li> <li tag="ref"><a name="C109" /><span class="label" tagx="label" title="label">109</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ohtawa</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Takayama</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saitoh</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans</span>. <span class="source" tagx="source" title="source">Br J Clin Pharmacol</span><span class="year" tagx="year" title="year">1993</span>; <span class="volume" tagx="volume" title="volume">35</span>: <span class="fpage" tagx="fpage" title="fpage">290</span>â€"<span class="lpage" tagx="lpage" title="lpage">297</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1365-2125.1993.tb05696.x">10.1111/j.1365-2125.1993.tb05696.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8471405">8471405</a></span></span></li> <li tag="ref"><a name="C110" /><span class="label" tagx="label" title="label">110</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reid</span><span class="given-names" tagx="given-names" title="given-names">JL</span></span></span><span class="mixed-article-title" title="mixed-article-title">Inhibitors of the renin-angiotensin system. Clinical pharmacology studies on kinetics, dynamics and concentration-effect relationships</span>. <span class="source" tagx="source" title="source">Arzneimittelforschung</span><span class="year" tagx="year" title="year">1993</span>; <span class="volume" tagx="volume" title="volume">43</span>: <span class="fpage" tagx="fpage" title="fpage">263</span>â€"<span class="lpage" tagx="lpage" title="lpage">264</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8498975">8498975</a></span></span></li> <li tag="ref"><a name="C111" /><span class="label" tagx="label" title="label">111</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meng</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiao</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension</span>. <span class="source" tagx="source" title="source">Emerg Microbes Infect</span><span class="year" tagx="year" title="year">2020</span>; <span class="volume" tagx="volume" title="volume">9</span>: <span class="fpage" tagx="fpage" title="fpage">757</span>â€"<span class="lpage" tagx="lpage" title="lpage">760</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1080/22221751.2020.1746200">10.1080/22221751.2020.1746200</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32228222">32228222</a></span></span></li> <li tag="ref"><a name="C112" /><span class="label" tagx="label" title="label">112</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bean</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kraljevic</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Searle</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="comment">Treatment with ACE-inhibitors is not associated with early severe SARS-Covid-19 infection in a multi-site UK acute Hospital Trust</span>, <span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C113" /><span class="label" tagx="label" title="label">113</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jazzi</span><span class="given-names" tagx="given-names" title="given-names">AS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mahnam</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hejazi</span><span class="given-names" tagx="given-names" title="given-names">SH</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="comment">Inhibition of Viral Macrodomain of COVID-19 and Human TRPM2 by losartan</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C114" /><span class="label" tagx="label" title="label">114</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="collab'">collab: International Society of Hypertension</span></span><span class="comment">A statement from the International Society of Hypertension on COVID-19 The International Society of Hypertension</span><span class="year" tagx="year" title="year">2020</span>.</span></li> <li tag="ref"><a name="C115" /><span class="label" tagx="label" title="label">115</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="comment">Hypertension Canada's Statement on: Hypertension, ACE-Inhibitors and Angiotensin Receptor Blockers and COVID-19</span><a href="https://hypertension.ca/wp-content/uploads/2020/03/2020-30-15-Hypertension-Canada-Statement-on-COVID-19-ACEi-ARB.pdf">https://hypertension.ca/wp-content/uploads/2020/03/2020-30-15-Hypertension-Canada-Statement-on-COVID-19-ACEi-ARB.pdf</a></span></li> <li tag="ref"><a name="C116" /><span class="label" tagx="label" title="label">116</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="comment">COVID-19 and concerns regarding use of ACEi/ARB/ARNi medications for heart failure or hypertension</span><a href="www.conferenceharvester.com/Uploads/Documents/9006/CCSCHFSstatementregardingCOVID.pdf">www.conferenceharvester.com/Uploads/Documents/9006/CCSCHFSstatementregardingCOVID.pdf</a></span></li> </ul> </div> </div>  </body></html>